<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Schizophrenia Spectrum Disorders - Psychology Presentation</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Inter', sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            overflow: hidden;
        }

        .presentation-container {
            width: 100%;
            height: 100vh;
            display: flex;
            align-items: center;
            justify-content: center;
            position: relative;
        }

        .slide {
            width: 90%;
            max-width: 1200px;
            height: 85vh;
            background: white;
            border-radius: 20px;
            box-shadow: 0 25px 50px -12px rgba(0, 0, 0, 0.25);
            padding: 60px;
            position: absolute;
            opacity: 0;
            transform: translateX(100%);
            transition: all 0.6s cubic-bezier(0.68, -0.55, 0.265, 1.55);
            overflow-y: auto;
        }

        .slide.active {
            opacity: 1;
            transform: translateX(0);
        }

        .slide.prev {
            transform: translateX(-100%);
        }

        h1 {
            color: #5B21B6;
            font-size: 2.5em;
            margin-bottom: 20px;
            font-weight: 700;
        }

        h2 {
            color: #6D28D9;
            font-size: 2em;
            margin-bottom: 20px;
            font-weight: 600;
        }

        h3 {
            color: #7C3AED;
            font-size: 1.5em;
            margin-bottom: 15px;
            font-weight: 600;
        }

        p {
            color: #4B5563;
            line-height: 1.8;
            margin-bottom: 15px;
            font-size: 1.1em;
        }

        .navigation {
            position: fixed;
            bottom: 40px;
            left: 50%;
            transform: translateX(-50%);
            display: flex;
            gap: 20px;
            z-index: 1000;
        }

        .nav-btn {
            background: #7C3AED;
            color: white;
            border: none;
            padding: 15px 30px;
            border-radius: 50px;
            font-size: 16px;
            cursor: pointer;
            transition: all 0.3s ease;
            box-shadow: 0 4px 15px rgba(124, 58, 237, 0.3);
        }

        .nav-btn:hover {
            background: #6D28D9;
            transform: translateY(-2px);
            box-shadow: 0 6px 20px rgba(124, 58, 237, 0.4);
        }

        .nav-btn:disabled {
            background: #D1D5DB;
            cursor: not-allowed;
            box-shadow: none;
        }

        .slide-number {
            position: absolute;
            top: 30px;
            right: 30px;
            background: #EDE9FE;
            color: #7C3AED;
            padding: 10px 20px;
            border-radius: 20px;
            font-weight: 600;
        }

        .chart-container {
            width: 100%;
            max-width: 600px;
            margin: 30px auto;
            padding: 20px;
            background: #F9FAFB;
            border-radius: 15px;
        }

        .image-placeholder {
            width: 100%;
            max-width: 500px;
            height: 300px;
            background: linear-gradient(135deg, #E0E7FF 0%, #C7D2FE 100%);
            border-radius: 15px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 20px auto;
            font-size: 1.2em;
            color: #6D28D9;
            text-align: center;
            padding: 20px;
        }

        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 40px;
            align-items: start;
        }

        .highlight-box {
            background: #F3F4F6;
            border-left: 4px solid #7C3AED;
            padding: 20px;
            margin: 20px 0;
            border-radius: 0 10px 10px 0;
        }

        .stat-box {
            background: linear-gradient(135deg, #EDE9FE 0%, #DDD6FE 100%);
            padding: 30px;
            border-radius: 15px;
            text-align: center;
            margin: 10px;
        }

        .stat-number {
            font-size: 3em;
            color: #7C3AED;
            font-weight: 700;
        }

        .stat-label {
            color: #6B7280;
            margin-top: 10px;
        }

        .button-group {
            display: flex;
            gap: 15px;
            margin: 30px 0;
            flex-wrap: wrap;
        }

        .info-btn {
            background: #7C3AED;
            color: white;
            border: none;
            padding: 12px 25px;
            border-radius: 25px;
            cursor: pointer;
            transition: all 0.3s ease;
            font-size: 14px;
            font-weight: 500;
        }

        .info-btn:hover {
            background: #6D28D9;
            transform: translateY(-2px);
            box-shadow: 0 4px 15px rgba(124, 58, 237, 0.3);
        }

        ul {
            list-style: none;
            padding-left: 0;
        }

        ul li {
            padding: 10px 0;
            padding-left: 30px;
            position: relative;
            color: #4B5563;
            line-height: 1.6;
        }

        ul li:before {
            content: "▸";
            position: absolute;
            left: 0;
            color: #7C3AED;
            font-weight: bold;
        }

        .timeline {
            position: relative;
            padding: 20px 0;
        }

        .timeline-item {
            position: relative;
            padding-left: 40px;
            margin-bottom: 30px;
        }

        .timeline-item:before {
            content: "";
            position: absolute;
            left: 8px;
            top: 8px;
            width: 16px;
            height: 16px;
            background: #7C3AED;
            border-radius: 50%;
        }

        .timeline-item:after {
            content: "";
            position: absolute;
            left: 15px;
            top: 24px;
            width: 2px;
            height: calc(100% + 14px);
            background: #E5E7EB;
        }

        .timeline-item:last-child:after {
            display: none;
        }

        .reference {
            font-size: 0.9em;
            color: #6B7280;
            margin: 5px 0;
            padding-left: 20px;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .fade-in {
            animation: fadeIn 0.6s ease-out;
        }

        .progress-bar {
            position: fixed;
            top: 0;
            left: 0;
            height: 4px;
            background: #7C3AED;
            transition: width 0.3s ease;
            z-index: 1001;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            border-radius: 10px;
            overflow: hidden;
        }

        th {
            background: #7C3AED;
            color: white;
            padding: 15px;
            text-align: left;
            font-weight: 600;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #E5E7EB;
        }

        tr:nth-child(even) {
            background: #F9FAFB;
        }

        .icon-box {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 60px;
            height: 60px;
            background: #EDE9FE;
            border-radius: 15px;
            margin-bottom: 20px;
            color: #7C3AED;
            font-size: 24px;
        }
        .modal {
        display: none;
        position: fixed;
        z-index: 2000;
        left: 0;
        top: 0;
        width: 100%;
        height: 100%;
        background-color: rgba(0,0,0,0.5);
        }

    .modal-content {
        background-color: white;
        margin: 5% auto;
        padding: 40px;
        border-radius: 20px;
        width: 80%;
        max-width: 800px;
        max-height: 80vh;
        overflow-y: auto;
        box-shadow: 0 25px 50px -12px rgba(0, 0, 0, 0.25);
    }

    .close {
        color: #aaa;
        float: right;
        font-size: 28px;
        font-weight: bold;
        cursor: pointer;
    }

    .close:hover {
        color: #7C3AED;
    }

    </style>
</head>
<body>
    <div id="modal" class="modal">
        <div class="modal-content">
            <span class="close">&times;</span>
            <h2 id="modalTitle"></h2>
            <div id="modalBody"></div>
        </div>
    </div>
    <div class="progress-bar" id="progressBar"></div>
    
    <div class="presentation-container">
        <!-- Slide 1: Title Slide -->
        <div class="slide active">
            <div class="slide-number">1 / 20</div>
            <div style="text-align: center; margin-top: 100px;">
                <div class="icon-box" style="margin: 0 auto 30px;">
                    <i class="fas fa-brain"></i>
                </div>
                <h1 style="font-size: 3.5em; margin-bottom: 30px;">Schizophrenia Spectrum Disorders</h1>
                <p style="font-size: 1.5em; color: #6B7280; margin-bottom: 40px;">Understanding the Complexity of Psychotic Disorders</p>
                <div class="button-group" style="justify-content: center;">
                    <button class="info-btn"><i class="fas fa-graduation-cap"></i> Psychology Class [SUNY]</button>
                    <button class="info-btn" onclick="alert('srijandsofficial@gmail.com/ssrijandev@gmail.com')"><i class="fas fa-calendar"></i> Email Me
                        </button>
                    
                </div>
                <div class="image-placeholder" style="margin-top: 50px;">
                    <img src="https://i0.wp.com/post.healthline.com/wp-content/uploads/2022/03/Schizophrenia-PET-Scan-body-1.jpg?w=1155&h=1528" 
                         alt="Brain MRI" 
                         style="width: 100%; height: auto; border-radius: 15px; margin-top: 20px;">
                    
                </div>
            </div>
        </div>

        <!-- Slide 2: Overview -->
        <div class="slide">
            <div class="slide-number">2 / 20</div>
            <h1>Overview of Presentation</h1>
            <div class="two-column">
                <div>
                    <h3>What We'll Cover:</h3>
                    <ul>
                        <li>Definition and History</li>
                        <li>Types of Schizophrenia Spectrum Disorders</li>
                        <li>Symptoms and Diagnosis</li>
                        <li>Neurobiological Factors</li>
                        <li>Treatment Approaches</li>
                        <li>Recent Research Findings</li>
                        <li>Case Studies</li>
                        <li>Future Directions</li>
                    </ul>
                </div>
                <div>
                    <div class="highlight-box">
                        <h3><i class="fas fa-lightbulb"></i> Learning Objectives</h3>
                        <p>By the end of this presentation, you will:</p>
                        <ul>
                            <li>Understand the diagnostic criteria</li>
                            <li>Recognize different types and symptoms</li>
                            <li>Know current treatment options</li>
                            <li>Be aware of recent research developments</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 3: Definition -->
        <div class="slide">
            <div class="slide-number">3 / 20</div>
            <h1>What is Schizophrenia?</h1>
            <div class="highlight-box">
                <p><strong>Definition:</strong> Schizophrenia is a chronic brain disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may experience hallucinations, delusions, and extremely disordered thinking.</p>
            </div>
            <div class="two-column" style="margin-top: 40px;">
                <div>
                    <h3>Key Characteristics:</h3>
                    <ul>
                        <li>Distortions in thinking</li>
                        <li>Distortions in perception</li>
                        <li>Distortions in emotions</li>
                        <li>Distortions in language</li>
                        <li>Distortions in sense of self</li>
                        <li>Distortions in behavior</li>
                    </ul>
                </div>
                <div>
                    <div class="stat-box">
                        <div class="stat-number">1%</div>
                        <div class="stat-label">of the population affected worldwide</div>
                    </div>
                    <div class="stat-box" style="margin-top: 20px;">
                        <div class="stat-number">20-30</div>
                        <div class="stat-label">Typical age of onset (years)</div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 4: Historical Perspective -->
        <div class="slide">
            <div class="slide-number">4 / 20</div>
            <h1>Historical Perspective</h1>
            <div class="timeline">
                <div class="timeline-item">
                    <h3>1887 - Emil Kraepelin</h3>
                    <p>First described "dementia praecox" - a progressive deteriorating psychotic disorder</p>
                </div>
                <div class="timeline-item">
                    <h3>1911 - Eugen Bleuler</h3>
                    <p>Coined the term "schizophrenia" meaning "split mind"</p>
                </div>
                <div class="timeline-item">
                    <h3>1950s - First Antipsychotics</h3>
                    <p>Chlorpromazine revolutionized treatment</p>
                </div>
                <div class="timeline-item">
                    <h3>1980 - DSM-III</h3>
                    <p>Standardized diagnostic criteria established</p>
                </div>
                <div class="timeline-item">
                    <h3>2013 - DSM-5</h3>
                    <p>Introduction of Schizophrenia Spectrum concept</p>
                </div>
            </div>
            <div class="button-group">
                <button class="info-btn"onclick="openLink('https://livingwithschizophreniauk.org/information-sheets/schizophrenia-a-brief-history/#:~:text=Swiss%20psychiatrist%20Eugen%20Bleuler%20who,a%20distinct%20improvement%20over%20time.')">
                    <i class="fas fa-book"></i> Learn More History</button>
                <button class="info-btn"onclick="openLink('https://en.wikipedia.org/wiki/History_of_schizophrenia')">
                    <i class="fas fa-user-md"></i> Key Researchers</button>
            </div>
        </div>

        <!-- Slide 5: Types of Schizophrenia Spectrum Disorders -->
        <div class="slide">
            <div class="slide-number">5 / 20</div>
            <h1>Schizophrenia Spectrum Disorders</h1>
            <table>
                <thead>
                    <tr>
                        <th>Disorder</th>
                        <th>Duration</th>
                        <th>Key Features</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Schizotypal Personality Disorder</strong></td>
                        <td>Lifelong pattern</td>
                        <td>Odd beliefs, behavior, and speech</td>
                    </tr>
                    <tr>
                        <td><strong>Delusional Disorder</strong></td>
                        <td>≥1 month</td>
                        <td>Fixed false beliefs without other symptoms</td>
                    </tr>
                    <tr>
                        <td><strong>Brief Psychotic Disorder</strong></td>
                        <td>1 day - 1 month</td>
                        <td>Sudden onset, often stress-related</td>
                    </tr>
                    <tr>
                        <td><strong>Schizophreniform Disorder</strong></td>
                        <td>1-6 months</td>
                        <td>Same as schizophrenia but shorter</td>
                    </tr>
                    <tr>
                        <td><strong>Schizophrenia</strong></td>
                        <td>≥6 months</td>
                        <td>Full syndrome with functional decline</td>
                    </tr>
                    <tr>
                        <td><strong>Schizoaffective Disorder</strong></td>
                        <td>Variable</td>
                        <td>Schizophrenia + mood episodes</td>
                    </tr>
                </tbody>
            </table>
            <div class="chart-container">
                <canvas id="spectrumChart"></canvas>
            </div>
        </div>

        <!-- Slide 6: Positive Symptoms -->
        <div class="slide">
            <div class="slide-number">6 / 20</div>
            <h1>Positive Symptoms</h1>
            <p style="font-style: italic; color: #7C3AED;">Experiences that are "added" to normal functioning</p>
            <div class="two-column">
                <div>
                    <div class="icon-box">
                        <i class="fas fa-eye"></i>
                    </div>
                    <h3>Hallucinations</h3>
                    <ul>
                        <li>Auditory (most common - 70%)</li>
                        <li>Visual (15-20%)</li>
                        <li>Tactile (feeling sensations)</li>
                        <li>Olfactory (smelling odors)</li>
                        <li>Gustatory (tasting)</li>
                    </ul>
                    
                    <div class="icon-box" style="margin-top: 30px;">
                        <i class="fas fa-comments"></i>
                    </div>
                    <h3>Disorganized Speech</h3>
                    <ul>
                        <li>Loose associations</li>
                        <li>Tangential thinking</li>
                        <li>Word salad</li>
                        <li>Neologisms</li>
                    </ul>
                </div>
                <div>
                    <div class="icon-box">
                        <i class="fas fa-head-side-virus"></i>
                    </div>
                    <h3>Delusions</h3>
                    <ul>
                        <li>Persecutory (most common)</li>
                        <li>Referential</li>
                        <li>Grandiose</li>
                        <li>Religious</li>
                        <li>Somatic</li>
                    </ul>
                    
                    <div class="icon-box" style="margin-top: 30px;">
                        <i class="fas fa-running"></i>
                    </div>
                    <h3>Disorganized Behavior</h3>
                    <ul>
                        <li>Unpredictable agitation</li>
                        <li>Bizarre postures</li>
                        <li>Excessive motor activity</li>
                        <li>Echopraxia</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Slide 7: Negative Symptoms -->
        <div class="slide">
            <div class="slide-number">7 / 20</div>
            <h1>Negative Symptoms</h1>
            <p style="font-style: italic; color: #7C3AED;">Absence or reduction of normal functions</p>
            <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 20px; margin-top: 40px;">
                <div class="stat-box">
                    <i class="fas fa-meh" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Affective Flattening</h3>
                    <p>Reduced emotional expression</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-comment-slash" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Alogia</h3>
                    <p>Poverty of speech</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-battery-empty" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Avolition</h3>
                    <p>Lack of motivation</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-frown" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Anhedonia</h3>
                    <p>Inability to experience pleasure</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-user-slash" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Asociality</h3>
                    <p>Social withdrawal</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-brain" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Cognitive Deficits</h3>
                    <p>Attention & memory issues</p>
                </div>
            </div>
            <div class="chart-container" style="max-width: 400px;">
                <canvas id="symptomsChart"></canvas>
            </div>
        </div>

        <!-- Slide 8: Diagnostic Criteria (DSM-5) -->
        <div class="slide">
            <div class="slide-number">8 / 20</div>
            <h1>DSM-5 Diagnostic Criteria</h1>
            <div class="highlight-box">
                <h3>Criterion A: Two or more of the following for ≥1 month:</h3>
                <ol style="padding-left: 20px; color: #4B5563;">
                    <li>Delusions</li>
                    <li>Hallucinations</li>
                    <li>Disorganized speech</li>
                    <li>Grossly disorganized or catatonic behavior</li>
                    <li>Negative symptoms</li>
                </ol>
            </div>
            <div class="two-column" style="margin-top: 30px;">
                <div>
                    <h3>Additional Criteria:</h3>
                    <ul>
                        <li><strong>B:</strong> Significant functional decline</li>
                        <li><strong>C:</strong> Continuous signs for ≥6 months</li>
                        <li><strong>D:</strong> Exclusion of other disorders</li>
                        <li><strong>E:</strong> Not due to substances</li>
                        <li><strong>F:</strong> If autism history, prominent delusions/hallucinations required</li>
                    </ul>
                </div>
                <div>
                    <div class="button-group">
                        <button class="info-btn"onclick="showContent('dsm5-checklist')"><i class="fas fa-download"></i> DSM-5 Checklist</button>
                        <button class="info-btn" onclick="downloadDSM5Checklist()"><i class="fas fa-download"></i> Download DSM-5 Checklist</button>
                        <button class="info-btn" onclick="showContent('panss-scale')"><i class="fas fa-stethoscope"></i> PANSS Scale</button>
                        <button class="info-btn" onclick="downloadPANSSForm()"><i class="fas fa-download"></i> Download PANSS Form</button>
                        <button class="info-btn" onclick="showContent('clinical-assessment-tools')">
        <i class="fas fa-stethoscope"></i> Clinical Assessment Tools
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 9: Neurobiological Factors -->
        <div class="slide">
            <div class="slide-number">9 / 20</div>
            <h1>Neurobiological Factors</h1>
            <div class="two-column">
                <div>
                    <h3><i class="fas fa-dna"></i> Genetic Factors</h3>
                    <div class="chart-container">
                        <canvas id="geneticsChart"></canvas>
                    </div>
                    <p>Risk increases with genetic proximity to affected individual</p>
                </div>
                <div>
                    <h3><i class="fas fa-brain"></i> Brain Abnormalities</h3>
                    <ul>
                        <li>Enlarged ventricles</li>
                        <li>Reduced gray matter</li>
                        <li>Frontal lobe dysfunction</li>
                        <li>Temporal lobe abnormalities</li>
                        <li>Hippocampal volume reduction</li>
                    </ul>
                    <div class="highlight-box" style="margin-top: 20px;">
                        <h4>Neurotransmitter Imbalances:</h4>
                        <p>• Dopamine (excess)<br>
                        • Glutamate (deficiency)<br>
                        • GABA (reduced)<br>
                        • Serotonin (altered)</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 10: Environmental Risk Factors -->
        <div class="slide">
            <div class="slide-number">10 / 20</div>
            <h1>Environmental Risk Factors</h1>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 30px;">
                <div class="highlight-box">
                    <h3><i class="fas fa-baby"></i> Prenatal & Perinatal</h3>
                    <ul>
                        <li>Maternal infections (influenza, toxoplasmosis)</li>
                        <li>Malnutrition during pregnancy</li>
                        <li>Birth complications</li>
                        <li>Low birth weight</li>
                        <li>Hypoxia during delivery</li>
                    </ul>
                </div>
                <div class="highlight-box">
                    <h3><i class="fas fa-city"></i> Environmental Stressors</h3>
                    <ul>
                        <li>Urban upbringing (2-3x risk)</li>
                        <li>Migration stress</li>
                        <li>Social isolation</li>
                        <li>Childhood trauma</li>
                        <li>Cannabis use in adolescence</li>
                    </ul>
                </div>
                <div class="highlight-box">
                    <h3><i class="fas fa-users"></i> Social Factors</h3>
                    <ul>
                        <li>Family dysfunction</li>
                        <li>Expressed emotion (criticism)</li>
                        <li>Social defeat</li>
                        <li>Discrimination</li>
                        <li>Poverty</li>
                    </ul>
                </div>
                <div class="highlight-box">
                    <h3><i class="fas fa-calendar"></i> Timing Factors</h3>
                    <ul>
                        <li>Season of birth (winter/spring)</li>
                        <li>Advanced paternal age</li>
                        <li>Adolescent stress</li>
                        <li>Critical developmental periods</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Slide 11: Treatment Approaches -->
        <div class="slide">
            <div class="slide-number">11 / 20</div>
            <h1>Treatment Approaches</h1>
            <div class="two-column">
                <div>
                    <h3><i class="fas fa-pills"></i> Pharmacological Treatment</h3>
                    <h4>First-Generation Antipsychotics:</h4>
                    <ul>
                        <li>Haloperidol</li>
                        <li>Chlorpromazine</li>
                        <li>Fluphenazine</li>
                    </ul>
                    <h4 style="margin-top: 20px;">Second-Generation Antipsychotics:</h4>
                    <ul>
                        <li>Risperidone</li>
                        <li>Olanzapine</li>
                        <li>Quetiapine</li>
                        <li>Aripiprazole</li>
                        <li>Clozapine (treatment-resistant)</li>
                    </ul>
                </div>
                <div>
                    <h3><i class="fas fa-comments"></i> Psychosocial Interventions</h3>
                    <ul>
                        <li>Cognitive Behavioral Therapy (CBT)</li>
                        <li>Family therapy</li>
                        <li>Social skills training</li>
                        <li>Cognitive remediation</li>
                                                <li>Vocational rehabilitation</li>
                        <li>Assertive Community Treatment (ACT)</li>
                    </ul>
                    <div class="stat-box" style="margin-top: 20px;">
                        <div class="stat-number">70%</div>
                        <div class="stat-label">Response rate with combined treatment</div>
                    </div>
                </div>
            </div>
            <div class="chart-container">
                <canvas id="treatmentChart"></canvas>
            </div>
        </div>

        <!-- Slide 12: Recent Research Study 1 -->
        <div class="slide">
            <div class="slide-number">12 / 20</div>
            <h1>Recent Research: Genetics</h1>
            <div class="highlight-box">
                <h3>Study: Nature (2022) - Schizophrenia Working Group</h3>
                <p><strong>Title:</strong> "Common schizophrenia alleles are enriched in mutation-intolerant genes"</p>
                <p><strong>Sample Size:</strong> 76,755 cases and 243,649 controls</p>
            </div>
            <div class="two-column">
                <div>
                    <h3>Key Findings:</h3>
                    <ul>
                        <li>287 genomic loci associated with schizophrenia</li>
                        <li>120 genes directly implicated</li>
                        <li>Synaptic organization pathways identified</li>
                        <li>Neuronal excitability genes involved</li>
                        <li>10 genes with therapeutic potential</li>
                    </ul>
                </div>
                <div>
                    <div class="chart-container">
                        <canvas id="researchChart1"></canvas>
                    </div>
                    <div class="button-group" style="margin-top: 20px;">
                        <button class="info-btn"onclick="openLink('https://www.nature.com/articles/s41586-022-04434-5')"><i class="fas fa-file-pdf"></i> Full Study</button>
                        <button class="info-btn"onclick="openLink('https://www.ncbi.nlm.nih.gov/gene')"><i class="fas fa-dna"></i> Gene Database</button>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 13: Recent Research Study 2 -->
        <div class="slide">
            <div class="slide-number">13 / 20</div>
            <h1>Recent Research: Brain Imaging</h1>
            <div class="highlight-box">
                <h3>Study: American Journal of Psychiatry (2023)</h3>
                <p><strong>Title:</strong> "Progressive Brain Changes in Schizophrenia: A 10-Year Longitudinal Study"</p>
                <p><strong>Methodology:</strong> MRI scans every 2 years, 189 patients vs 158 controls</p>
            </div>
            <div class="two-column">
                <div>
                    <h3>Brain Volume Changes:</h3>
                    <div class="chart-container">
                        <canvas id="brainChart"></canvas>
                    </div>
                </div>
                <div>
                    <h3>Clinical Implications:</h3>
                    <ul>
                        <li>Early intervention crucial</li>
                        <li>Neuroprotective strategies needed</li>
                        <li>Medication adherence important</li>
                        <li>Cognitive training beneficial</li>
                    </ul>
    <!-- New MRI Comparison Section -->
    <div style="margin-top: 40px;">
        <h3 style="text-align: center; margin-bottom: 20px;">MRI Brain Scan Comparison</h3>
        <div class="mri-comparison">
            <div class="mri-container">
                <h4>Healthy Control</h4>
                <div class="brain-scan healthy">
                    <div class="brain-region ventricles"></div>
                    <div class="brain-region gray-matter"></div>
                    <div class="brain-region white-matter"></div>
                    <div class="scan-label">Normal ventricle size</div>
                    <div class="scan-label bottom">Intact gray matter</div>
                </div>
                <div class="scan-info">
                    <p><i class="fas fa-check-circle" style="color: #10B981;"></i> Normal ventricles</p>
                    <p><i class="fas fa-check-circle" style="color: #10B981;"></i> Preserved gray matter</p>
                    <p><i class="fas fa-check-circle" style="color: #10B981;"></i> Intact hippocampus</p>
                </div>
            </div>                
            
                <h4>Schizophrenia Patient</h4>
                <div class="brain-scan schizophrenia">
                    <div class="brain-region ventricles enlarged"></div>
                    <div class="brain-region gray-matter reduced"></div>
                    <div class="brain-region white-matter"></div>
                    <div class="scan-label">Enlarged ventricles</div>
                    <div class="scan-label bottom">Reduced gray matter</div>
                </div>
                <div class="scan-info">
                    <p><i class="fas fa-exclamation-circle" style="color: #EF4444;"></i> Enlarged ventricles</p>
                    <p><i class="fas fa-exclamation-circle" style="color: #EF4444;"></i> Gray matter loss</p>
                    <p><i class="fas fa-exclamation-circle" style="color: #EF4444;"></i> Hippocampal atrophy</p>
                </div>
            </div>
        </div>
        
        <div class="image-note">
            <p><i class="fas fa-info-circle"></i> <strong>Note:</strong> These are simplified representations. Actual MRI scans would show more detailed structural differences.</p>
        </div>
        
        
                </div>
            </div>
        </div>

        <!-- Slide 14: Case Study 1 -->
        <div class="slide">
            <div class="slide-number">14 / 20</div>
            <h1>Case Study: Early-Onset Schizophrenia</h1>
            <div class="highlight-box">
                <h3>Patient Profile: "James"</h3>
                <p><strong>Age:</strong> 22 years old | <strong>Gender:</strong> Male | <strong>Onset:</strong> Age 18</p>
            </div>
            <div class="timeline">
                <div class="timeline-item">
                    <h4>Age 16-17: Prodromal Phase</h4>
                    <p>Social withdrawal, declining grades, unusual beliefs about classmates</p>
                </div>
                <div class="timeline-item">
                    <h4>Age 18: First Episode</h4>
                    <p>Auditory hallucinations, paranoid delusions, hospitalization</p>
                </div>
                <div class="timeline-item">
                    <h4>Age 19-20: Treatment</h4>
                    <p>Started on risperidone, CBT, family therapy</p>
                </div>
                <div class="timeline-item">
                    <h4>Age 21-22: Recovery</h4>
                    <p>Returned to college part-time, minimal symptoms, good medication adherence</p>
                </div>
            </div>
            <div class="button-group">
                <button class="info-btn"onclick="showContent('james-treatment-timeline')"><i class="fas fa-chart-line"></i> Treatment Timeline</button>
                <button class="info-btn"onclick="showContent('james-clinical-notes')"><i class="fas fa-notes-medical"></i> Clinical Notes</button>
                <button class="info-btn" onclick="openLink('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930984/')">
            <i class="fas fa-book-medical"></i> Similar Cases</button>
            </div>
        </div>

        <!-- Slide 15: Case Study 2 -->
        <div class="slide">
            <div class="slide-number">15 / 20</div>
            <h1>Case Study: Treatment-Resistant Schizophrenia</h1>
            <div class="highlight-box">
                <h3>Patient Profile: "Sarah"</h3>
                <p><strong>Age:</strong> 35 years old | <strong>Gender:</strong> Female | <strong>Onset:</strong> Age 23 | <strong>Duration:</strong> 12 years</p>
            </div>
            <table>
                <thead>
                    <tr>
                        <th>Medication Trial</th>
                        <th>Duration</th>
                        <th>Response</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Risperidone</td>
                        <td>8 months</td>
                        <td>Partial response, weight gain</td>
                    </tr>
                    <tr>
                        <td>Olanzapine</td>
                        <td>6 months</td>
                        <td>Minimal improvement</td>
                    </tr>
                    <tr>
                        <td>Aripiprazole</td>
                        <td>10 months</td>
                        <td>No significant change</td>
                    </tr>
                    <tr>
                        <td>Clozapine</td>
                        <td>Ongoing (2 years)</td>
                        <td>70% symptom reduction</td>
                    </tr>
                </tbody>
            </table>
            <div class="highlight-box" style="margin-top: 20px;">
                <p><strong>Key Learning:</strong> Clozapine remains the gold standard for treatment-resistant schizophrenia, with regular blood monitoring required.</p>
            </div>
        </div>

        <!-- Slide 16: Prognosis and Outcomes -->
        <div class="slide">
            <div class="slide-number">16 / 20</div>
            <h1>Prognosis and Long-term Outcomes</h1>
            <div class="chart-container" style="max-width: 800px;">
                <canvas id="prognosisChart"></canvas>
            </div>
            <div class="two-column" style="margin-top: 40px;">
                <div>
                    <h3>Favorable Prognostic Factors:</h3>
                    <ul>
                        <li>Later age of onset</li>
                        <li>Acute onset</li>
                        <li>Good premorbid functioning</li>
                        <li>Married/strong social support</li>
                        <li>Positive symptoms predominant</li>
                        <li>Good treatment adherence</li>
                    </ul>
                </div>
                <div>
                    <h3>Poor Prognostic Factors:</h3>
                    <ul>
                        <li>Early age of onset</li>
                        <li>Insidious onset</li>
                        <li>Poor premorbid functioning</li>
                        <li>Social isolation</li>
                        <li>Negative symptoms predominant</li>
                        <li>Substance abuse</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Slide 17: Future Directions -->
        <div class="slide">
            <div class="slide-number">17 / 20</div>
            <h1>Future Directions in Research</h1>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 30px;">
                <div class="stat-box">
                    <i class="fas fa-microscope" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Precision Medicine</h3>
                    <p>Genetic markers for treatment selection</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-robot" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Digital Therapeutics</h3>
                    <p>Apps for symptom monitoring and CBT</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-brain" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Neuromodulation</h3>
                    <p>TMS and tDCS for cognitive symptoms</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-syringe" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Novel Medications</h3>
                    <p>Glutamate and GABA modulators</p>
                </div>
            </div>
            <div class="highlight-box" style="margin-top: 30px;">
                <h3>Emerging Areas:</h3>
                <ul>
                    <li>Immunopsychiatry - role of inflammation</li>
                    <li>Gut-brain axis research</li>
                    <li>Early detection biomarkers</li>
                    <li>Virtual reality therapy</li>
                    <li>Peer support networks</li>
                </ul>
            </div>
        </div>

        <!-- Slide 18: Key Takeaways -->
        <div class="slide">
            <div class="slide-number">18 / 20</div>
            <h1>Key Takeaways</h1>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 30px; margin-top: 40px;">
                <div class="highlight-box">
                    <h3>1. Complex Disorder</h3>
                    <p>Schizophrenia involves multiple brain systems and has diverse presentations</p>
                </div>
                <div class="highlight-box">
                    <h3>2. Spectrum Concept</h3>
                    <p>Recognition of various related disorders with different durations and severities</p>
                </div>
                <div class="highlight-box">
                    <h3>3. Multifactorial Etiology</h3>
                    <p>Genetic vulnerability + environmental factors = increased risk</p>
                </div>
                <div class="highlight-box">
                    <h3>4. Treatment Works</h3>
                    <p>Combination of medication and psychosocial interventions most effective</p>
                </div>
                <div class="highlight-box">
                    <h3>5. Early Intervention</h3>
                    <p>Better outcomes with prompt treatment during first episode</p>
                </div>
                <div class="highlight-box">
                    <h3>6. Hope for Recovery</h3>
                    <p>Many individuals lead fulfilling lives with proper treatment and support</p>
                </div>
            </div>
        </div>

        <!-- Slide 19: References -->
        <div class="slide">
            <div class="slide-number">19 / 20</div>
            <h1>References</h1>
            <div style="max-height: 500px; overflow-y: auto;">
                <p class="reference">1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.</p>
                <p class="reference">2. Trubetskoy, V., et al. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.</p>
                <p class="reference">3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180
                                <p class="reference">3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180(2), 156-168.</p>
                <p class="reference">4. Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687.</p>
                <p class="reference">5. Leucht, S., et al. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia. Schizophrenia Bulletin, 43(4), 837-851.</p>
                <p class="reference">6. McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophrenia—an overview. JAMA Psychiatry, 77(2), 201-210.</p>
                <p class="reference">7. Millan, M. J., et al. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485-515.</p>
                <p class="reference">8. Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97.</p>
                <p class="reference">9. Ripke, S., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427.</p>
                <p class="reference">10. Stahl, S. M. (2018). Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis. CNS Spectrums, 23(3), 187-191.</p>
                <p class="reference">11. Van Os, J., & Kapur, S. (2009). Schizophrenia. The Lancet, 374(9690), 635-645.</p>
                <p class="reference">12. World Health Organization. (2022). Schizophrenia Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia</p>
                <p class="reference">13. Jauhar, S., et al. (2022). Cognitive-behavioural therapy for the symptoms of schizophrenia. The British Journal of Psychiatry, 220(3), 134-142.</p>
                <p class="reference">14. Kane, J. M., & Correll, C. U. (2022). Treatment-resistant schizophrenia: Definition and assessment. The Journal of Clinical Psychiatry, 83(5), MS21078COM5.</p>
                    <button class="info-btn" onclick="downloadReferences()">
    <i class="fas fa-download"></i> Download All References
</button>
            </div>
        </div>

        <!-- Slide 20: Thank You -->
<div class="slide">
    <div class="slide-number">20 / 20</div>
    <div style="text-align: center; margin-top: 150px;">
        <div class="icon-box" style="margin: 0 auto 30px; width: 100px; height: 100px; font-size: 40px;">
            <i class="fas fa-heart"></i>
        </div>
        <h1 style="font-size: 3em;">Thank You!</h1>
        <p style="font-size: 1.5em; color: #6B7280; margin: 30px 0;">Questions & Discussion</p>
        
        <div style="background: #F3F4F6; padding: 20px; border-radius: 15px; max-width: 600px; margin: 30px auto;">
            <h3 style="color: #7C3AED; margin-bottom: 15px;">Presented by: Srijan Dev</h3>
            <p style="color: #6B7280;"><i class="fas fa-phone"></i> +91 9412012157</p>
            <p style="color: #6B7280;"><i class="fas fa-envelope"></i> srijandsofficial@gmail.com</p>
        </div>
        
        <div class="button-group" style="justify-content: center;">
            <button class="info-btn" onclick="showContent('contact')">
                <i class="fas fa-envelope"></i> Contact Me
            </button>
            <button class="info-btn" onclick="downloadPresentationSummary()"><i class="fas fa-file-code"></i> Download HTML Summary</button>

            <button class="info-btn" onclick="downloadPrintableSummary()"><i class="fas fa-print"></i> Print Summary</button>
            <button class="info-btn" onclick="openLink('https://www.nimh.nih.gov/health/topics/schizophrenia')">
                <i class="fas fa-book"></i> Additional Resources
            </button>
            <button class="info-btn" onclick="downloadAllMaterials()"><i class="fas fa-download"></i> Download Complete Package</button>
        </div>
        
        <div style="margin-top: 50px;">
            <p style="color: #9CA3AF;">Psychology | 2025</p>
        </div>
    </div>
</div>

    <div class="navigation">
        <button class="nav-btn" id="prevBtn" onclick="changeSlide(-1)">
            <i class="fas fa-chevron-left"></i> Previous
        </button>
        <button class="nav-btn" id="nextBtn" onclick="changeSlide(1)">
            Next <i class="fas fa-chevron-right"></i>
        </button>
    </div>

    <script>
        let currentSlide = 0;
        const slides = document.querySelectorAll('.slide');
        const totalSlides = slides.length;
        const progressBar = document.getElementById('progressBar');

        function showSlide(n) {
            slides.forEach((slide, index) => {
                slide.classList.remove('active', 'prev');
                if (index < n) {
                    slide.classList.add('prev');
                }
            });
            
            if (n >= 0 && n < totalSlides) {
                slides[n].classList.add('active');
                currentSlide = n;
                
                // Update progress bar
                const progress = ((n + 1) / totalSlides) * 100;
                progressBar.style.width = progress + '%';
                
                // Update navigation buttons
                document.getElementById('prevBtn').disabled = n === 0;
                document.getElementById('nextBtn').disabled = n === totalSlides - 1;
                
                // Initialize charts when their slides are shown
                initializeCharts(n);
            }
        }

        function changeSlide(direction) {
            const newSlide = currentSlide + direction;
            if (newSlide >= 0 && newSlide < totalSlides) {
                showSlide(newSlide);
            }
        }

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            if (e.key === 'ArrowLeft') changeSlide(-1);
            if (e.key === 'ArrowRight') changeSlide(1);
        });
        

        // Initialize charts
        function initializeCharts(slideNumber) {
            switch(slideNumber) {
                case 4: // Spectrum Chart
                    if (!document.getElementById('spectrumChart').chart) {
                        const ctx = document.getElementById('spectrumChart').getContext('2d');
                        document.getElementById('spectrumChart').chart = new Chart(ctx, {
                            type: 'bar',
                            data: {
                                labels: ['Schizotypal PD', 'Delusional', 'Brief Psychotic', 'Schizophreniform', 'Schizophrenia', 'Schizoaffective'],
                                datasets: [{
                                    label: 'Typical Duration (months)',
                                    data: [999, 6, 0.5, 3, 12, 999],
                                    backgroundColor: '#7C3AED',
                                    borderColor: '#6D28D9',
                                    borderWidth: 2
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: true,
                                        title: {
                                            display: true,
                                            text: 'Duration (months)'
                                        }
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 6: // Symptoms Chart
                    if (!document.getElementById('symptomsChart').chart) {
                        const ctx = document.getElementById('symptomsChart').getContext('2d');
                        document.getElementById('symptomsChart').chart = new Chart(ctx, {
                            type: 'doughnut',
                            data: {
                                labels: ['Positive Symptoms', 'Negative Symptoms', 'Cognitive Symptoms'],
                                datasets: [{
                                    data: [35, 40, 25],
                                    backgroundColor: ['#7C3AED', '#A78BFA', '#C4B5FD'],
                                    borderWidth: 0
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                plugins: {
                                    legend: {
                                        position: 'bottom'
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 8: // Genetics Chart
                    if (!document.getElementById('geneticsChart').chart) {
                        const ctx = document.getElementById('geneticsChart').getContext('2d');
                        document.getElementById('geneticsChart').chart = new Chart(ctx, {
                            type: 'bar',
                            data: {
                                labels: ['General Population', 'Sibling', 'Fraternal Twin', 'Identical Twin', 'Both Parents'],
                                datasets: [{
                                    label: 'Risk of Schizophrenia (%)',
                                    data: [1, 9, 17, 48, 46],
                                    backgroundColor: '#7C3AED',
                                    borderColor: '#6D28D9',
                                    borderWidth: 2
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: true,
                                        max: 50,
                                        title: {
                                            display: true,
                                            text: 'Risk Percentage'
                                        }
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 10: // Treatment Chart
                    if (!document.getElementById('treatmentChart').chart) {
                        const ctx = document.getElementById('treatmentChart').getContext('2d');
                        document.getElementById('treatmentChart').chart = new Chart(ctx, {
                            type: 'line',
                            data: {
                                labels: ['Baseline', '2 weeks', '4 weeks', '8 weeks', '12 weeks', '6 months'],
                                datasets: [{
                                    label: 'Medication Only',
                                    data: [100, 85, 70, 60, 50, 45],
                                    borderColor: '#A78BFA',
                                    backgroundColor: 'rgba(167, 139, 250, 0.1)',
                                    tension: 0.4
                                }, {
                                    label: 'Combined Treatment',
                                    data: [100, 80, 60, 45, 35, 30],
                                    borderColor: '#7C3AED',
                                    backgroundColor: 'rgba(124, 58, 237, 0.1)',
                                    tension: 0.4
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: true,
                                        max: 100,
                                        title: {
                                            display: true,
                                            text: 'Symptom Severity (%)'
                                        }
                                    }
                                },
                                plugins: {
                                    title: {
                                        display: true,
                                        text: 'Treatment Response Over Time'
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 11: // Research Chart 1
                    if (!document.getElementById('researchChart1').chart) {
                        const ctx = document.getElementById('researchChart1').getContext('2d');
                        document.getElementById('researchChart1').chart = new Chart(ctx, {
                            type: 'radar',
                            data: {
                                labels: ['Synaptic', 'Neuronal', 'Immune', 'Metabolic', 'Developmental'],
                                datasets: [{
                                    label: 'Gene Involvement',
                                    data: [85, 70, 45, 30, 60],
                                    borderColor: '#7C3AED',
                                    backgroundColor: 'rgba(124, 58, 237, 0.2)',
                                    pointBackgroundColor: '#7C3AED'
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    r: {
                                        beginAtZero: true,
                                        max: 100
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 12: // Brain Chart
                    if (!document.getElementById('brainChart').chart) {
                        const ctx = document.getElementById('brainChart').getContext('2d');
                        document.getElementById('brainChart').chart = new Chart(ctx, {
                            type: 'line',
                            data: {
                                labels: ['Baseline', 'Year 2', 'Year 4', 'Year 6', 'Year 8', 'Year 10'],
                                datasets: [{
                                    label: 'Patients',
                                    data: [100, 98, 95, 93, 91, 89],
                                    borderColor: '#DC2626',
                                    backgroundColor: 'rgba(220, 38, 38, 0.1)',
                                    tension: 0.4
                                }, {
                                    label: 'Controls',
                                    data: [100, 99.5, 99, 98.5, 98, 97.5],
                                    borderColor: '#10B981',
                                    backgroundColor: 'rgba(16, 185, 129, 0.1)',
                                    tension: 0.4
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: false,
                                        min: 85,
                                        max: 101,
                                        title: {
                                            display: true,
                                            text: 'Gray Matter Volume (%)'
                                        }
                                    }
                                },
                                plugins: {
                                    title: {
                                        display: true,
                                        text: 'Longitudinal Brain Volume Changes'
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 15: // Prognosis Chart
                    if (!document.getElementById('prognosisChart').chart) {
                        const ctx = document.getElementById('prognosisChart').getContext('2d');
                        document.getElementById('prognosisChart').chart = new Chart(ctx, {
                            type: 'pie',
                            data: {
                                labels: ['Good Recovery (25%)', 'Moderate Improvement (35%)', 'Limited Improvement (25%)', 'Poor Outcome (15%)'],
                                datasets: [{
                                    data: [25, 35, 25, 15],
                                    backgroundColor: ['#10B981', '#3B82F6', '#F59E0B', '#EF4444'],
                                    borderWidth: 0
                                }]
                            },
                                                        options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                plugins: {
                                    title: {
                                        display: true,
                                        text: 'Long-term Outcomes in Schizophrenia',
                                        font: {
                                            size: 16
                                        }
                                    },
                                    legend: {
                                        position: 'bottom'
                                    }
                                }
                            }
                        });
                    }
                    break;
            }
        }

        // Initialize first slide
        showSlide(0);

        // Add smooth scrolling for slides with overflow
        document.querySelectorAll('.slide').forEach(slide => {
            slide.addEventListener('wheel', (e) => {
                if (slide.scrollHeight > slide.clientHeight) {
                    e.stopPropagation();
                }
            });
        });

        // Add touch support for mobile devices
        let touchStartX = 0;
        let touchEndX = 0;

        document.addEventListener('touchstart', (e) => {
            touchStartX = e.changedTouches[0].screenX;
        });

        document.addEventListener('touchend', (e) => {
            touchEndX = e.changedTouches[0].screenX;
            handleSwipe();
        });

        function handleSwipe() {
            if (touchEndX < touchStartX - 50) {
                changeSlide(1); // Swipe left, go to next slide
            }
            if (touchEndX > touchStartX + 50) {
                changeSlide(-1); // Swipe right, go to previous slide
            }
        }

        // Add fullscreen support
        document.addEventListener('keydown', (e) => {
            if (e.key === 'f' || e.key === 'F') {
                if (!document.fullscreenElement) {
                    document.documentElement.requestFullscreen();
                } else {
                    document.exitFullscreen();
                }
            }
        });

        // Add loading animation for charts
        Chart.defaults.animation.duration = 1000;
        Chart.defaults.animation.easing = 'easeInOutQuart';

        // Preload all slides content
        window.addEventListener('load', () => {
            slides.forEach((slide, index) => {
                slide.style.display = 'block';
                setTimeout(() => {
                    if (index !== 0) {
                        slide.style.display = '';
                    }
                }, 100);
            });
        });

        // Add print support
        window.addEventListener('beforeprint', () => {
            slides.forEach(slide => {
                slide.classList.add('active');
                slide.style.position = 'relative';
                slide.style.opacity = '1';
                slide.style.transform = 'none';
                slide.style.pageBreakAfter = 'always';
            });
        });

        window.addEventListener('afterprint', () => {
            showSlide(currentSlide);
            slides.forEach(slide => {
                slide.style.position = '';
                slide.style.pageBreakAfter = '';
            });
        });
    // Button click handlers
function openLink(url) {
    window.open(url, '_blank');
}

function showContent(contentId) {
    const modal = document.getElementById('modal');
    const modalTitle = document.getElementById('modalTitle');
    const modalBody = document.getElementById('modalBody');
    
    const content = buttonContentData[contentId];
    if (content) {
        modalTitle.textContent = content.title;
        modalBody.innerHTML = content.body;
        modal.style.display = 'block';
    }
}
 // Function to show modal content
    function showContent(contentId) {
        const modal = document.getElementById('modal');
        const modalTitle = document.getElementById('modalTitle');
        const modalBody = document.getElementById('modalBody');
        
        const content = buttonContentData[contentId];
        if (content) {
            modalTitle.textContent = content.title;
            modalBody.innerHTML = content.body;
            modal.style.display = 'block';
        } else {
            console.error('Content not found for:', contentId);
        }
    }

    // Function to open external links
    function openLink(url) {
        window.open(url, '_blank');
    }

    // Modal close functionality
    document.addEventListener('DOMContentLoaded', function() {
        const modal = document.getElementById('modal');
        const closeBtn = document.getElementsByClassName('close')[0];
        
        if (closeBtn) {
            closeBtn.onclick = function() {
                modal.style.display = 'none';
            }
        }
        
        // Close modal when clicking outside
        window.onclick = function(event) {
            if (event.target == modal) {
                modal.style.display = 'none';
            }
        }
    });
// ADD ALL OF THIS:
    
    // Button content data object
    // (Removed duplicate declaration to avoid redeclaration error)
// Button content data

const buttonContentData = {
        'dsm5-checklist': {
            title: 'DSM-5 Diagnostic Checklist for Schizophrenia',
            body: `
                <div class="modal-list">
                    <h3>Criterion A: Two or more of the following for ≥1 month:</h3>
                    <div style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin: 15px 0;">
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>1. Delusions</strong> - Fixed false beliefs
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>2. Hallucinations</strong> - Perceptual experiences without stimuli
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>3. Disorganized speech</strong> - Derailment or incoherence
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>4. Disorganized/catatonic behavior</strong>
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>5. Negative symptoms</strong> - Diminished emotional expression
                        </label>
                    </div>
                    
                    <h3 style="margin-top: 20px;">Additional Criteria:</h3>
                    <div style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin: 15px 0;">
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>B:</strong> Significant functional decline in work, relationships, or self-care
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>C:</strong> Continuous signs persist for at least 6 months
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>D:</strong> Schizoaffective and mood disorders ruled out
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>E:</strong> Not due to substance use or medical condition
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>F:</strong> If autism history, prominent hallucinations/delusions present
                        </label>
                    </div>
                    
                    <div style="margin-top: 20px; text-align: center;">
                        <button class="info-btn" onclick="window.print()">
                            <i class="fas fa-print"></i> Print Checklist
                        </button>
                        <button class="info-btn" onclick="openLink('https://www.psychiatry.org/psychiatrists/practice/dsm')" style="margin-left: 10px;">
                            <i class="fas fa-external-link-alt"></i> Official DSM-5 Website
                        </button>
                    </div>
                </div>
            `
        },
    'panss-scale': {
            title: 'PANSS - Positive and Negative Syndrome Scale',
            body: `
                <div class="resource-card">
                    <h4>About PANSS</h4>
                    <p>The PANSS is a 30-item rating scale for measuring symptom severity in schizophrenia.</p>
                    
                    <h4 style="margin-top: 20px;">Scale Components:</h4>
                    <ul>
                        <li><strong>Positive Scale (7 items):</strong> P1-P7</li>
                        <li><strong>Negative Scale (7 items):</strong> N1-N7</li>
                        <li><strong>General Psychopathology (16 items):</strong> G1-G16</li>
                    </ul>
                    
                    <h4 style="margin-top: 20px;">Scoring:</h4>
                    <p>Each item rated 1-7 (1 = absent, 7 = extreme)</p>
                    
                    <div style="margin-top: 20px;">
                        <button class="info-btn" onclick="openLink('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219910/')">
                            <i class="fas fa-file-pdf"></i> PANSS Manual
                        </button>
                    </div>
                </div>
            `
        },
        'james-treatment-timeline': {
        title: 'James - Detailed Treatment Timeline',
        body: `
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 1: Prodromal Period (Age 16-17)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Duration:</strong> 18 months</li>
                    <li style="margin: 8px 0;"><strong>Symptoms:</strong> Social anxiety, odd beliefs, concentration difficulties</li>
                    <li style="margin: 8px 0;"><strong>Interventions:</strong> School counseling, family meetings</li>
                    <li style="margin: 8px 0;"><strong>Outcome:</strong> Limited improvement, symptoms progressed</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 2: First Episode (Age 18)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Duration:</strong> 3 months acute phase</li>
                    <li style="margin: 8px 0;"><strong>Symptoms:</strong> Command hallucinations, paranoid delusions, disorganized thinking</li>
                    <li style="margin: 8px 0;"><strong>Interventions:</strong> 
                        <ul style="margin-left: 20px; margin-top: 5px;">
                            <li>Hospitalization (21 days)</li>
                            <li>Risperidone 2mg titrated to 4mg/day</li>
                            <li>Lorazepam PRN for agitation</li>
                        </ul>
                    </li>
                    <li style="margin: 8px 0;"><strong>Outcome:</strong> 60% symptom reduction, able to return home</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 3: Stabilization (Age 19-20)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Medications:</strong> Risperidone 3mg/day (maintenance dose)</li>
                    <li style="margin: 8px 0;"><strong>Therapy:</strong> 
                        <ul style="margin-left: 20px; margin-top: 5px;">
                            <li>Weekly CBT for psychosis (CBTp)</li>
                            <li>Monthly family therapy</li>
                            <li>Bi-weekly medication management</li>
                        </ul>
                    </li>
                    <li style="margin: 8px 0;"><strong>Support Services:</strong> Case management, vocational rehabilitation</li>
                    <li style="margin: 8px 0;"><strong>Outcome:</strong> Achieved clinical remission, enrolled in online courses</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 4: Recovery & Maintenance (Age 21-22)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Current Status:</strong> Part-time college student (12 credits)</li>
                    <li style="margin: 8px 0;"><strong>Medications:</strong> Risperidone 2mg/day (reduced dose)</li>
                    <li style="margin: 8px 0;"><strong>Ongoing Support:</strong> 
                        <ul style="margin-left: 20px; margin-top: 5px;">
                            <li>Monthly psychiatry appointments</li>
                            <li>Peer support group (weekly)</li>
                            <li>Academic accommodations</li>
                        </ul>
                    </li>
                    <li style="margin: 8px 0;"><strong>Functioning:</strong> Living independently with roommate, part-time job at library</li>
                </ul>
            </div>
        `
    },
    'james-clinical-notes': {
        title: 'James - Clinical Notes Summary',
        body: `
            <div style="background: #FEF3C7; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #92400E; margin-bottom: 15px;">Initial Presentation (Age 18)</h4>
                <p><strong>Chief Complaint:</strong> "People are watching me and controlling my thoughts through the WiFi"</p>
                <p><strong>Mental Status Exam:</strong></p>
                <ul style="margin-left: 20px;">
                    <li>Appearance: Disheveled, poor hygiene</li>
                    <li>Behavior: Guarded, covering ears intermittently</li>
                    <li>Speech: Tangential, increased latency</li>
                    <li>Mood: "Scared"</li>
                    <li>Affect: Restricted, fearful</li>
                    <li>Thought Process: Disorganized</li>
                    <li>Thought Content: Paranoid delusions, ideas of reference</li>
                    <li>Perceptions: Auditory hallucinations (commanding)</li>
                    <li>Insight/Judgment: Poor/Impaired</li>
                </ul>
            </div>
            
            <h4 style="color: #7C3AED; margin: 20px 0;">Treatment Progress - Assessment Scores</h4>
            <table style="width: 100%; border-collapse: collapse; background: white; border-radius: 10px; overflow: hidden; box-shadow: 0 2px 10px rgba(0,0,0,0.1);">
                <thead>
                    <tr style="background: #7C3AED; color: white;">
                        <th style="padding: 15px; text-align: left;">Assessment Tool</th>
                        <th style="padding: 15px; text-align: center;">Baseline</th>
                        <th style="padding: 15px; text-align: center;">3 Months</th>
                        <th style="padding: 15px; text-align: center;">6 Months</th>
                        <th style="padding: 15px; text-align: center;">Current (2 years)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr style="background: #F9FAFB;">
                        <td style="padding: 15px;">PANSS Total</td>
                        <td style="padding: 15px; text-align: center;">95</td>
                        <td style="padding: 15px; text-align: center;">72</td>
                        <td style="padding: 15px; text-align: center;">62</td>
                        <td style="padding: 15px; text-align: center;">48</td>
                    </tr>
                    <tr>
                        <td style="padding: 15px;">PANSS Positive</td>
                        <td style="padding: 15px; text-align: center;">28</td>
                        <td style="padding: 15px; text-align: center;">18</td>
                        <td style="padding: 15px; text-align: center;">14</td>
                        <td style="padding: 15px; text-align: center;">10</td>
                    </tr>
                    <tr style="background: #F9FAFB;">
                        <td style="padding: 15px;">PANSS Negative</td>
                        <td style="padding: 15px; text-align: center;">24</td>
                        <td style="padding: 15px; text-align: center;">20</td>
                        <td style="padding: 15px; text-align: center;">18</td>
                        <td style="padding: 15px; text-align: center;">15</td>
                    </tr>
                    <tr>
                        <td style="padding: 15px;">GAF Score</td>
                        <td style="padding: 15px; text-align: center;">25</td>
                        <td style="padding: 15px; text-align: center;">45</td>
                        <td style="padding: 15px; text-align: center;">55</td>
                        <td style="padding: 15px; text-align: center;">72</td>
                    </tr>
                    <tr style="background: #F9FAFB;">
                        <td style="padding: 15px;">CGI-Severity</td>
                        <td style="padding: 15px; text-align: center;">6 (Severely ill)</td>
                        <td style="padding: 15px; text-align: center;">4 (Moderately ill)</td>
                        <td style="padding: 15px; text-align: center;">3 (Mildly ill)</td>
                        <td style="padding: 15px; text-align: center;">2 (Borderline ill)</td>
                    </tr>
                </tbody>
            </table>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-top: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Clinical Observations & Strengths:</h4>
                <ul>
                    <li>Excellent medication adherence after initial psychoeducation</li>
                    <li>Strong family support system (parents very involved)</li>
                    <li>Good premorbid functioning (B+ student before onset)</li>
                    <li>Developed good insight over treatment course</li>
                    <li>No comorbid substance use</li>
                    <li>Highly motivated for recovery</li>
                    <li>Responsive to CBT interventions</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #FEE2E2; padding: 20px; border-radius: 10px; margin-top: 20px;">
                <h4 style="color: #DC2626; margin-bottom: 15px;">Risk Factors & Monitoring:</h4>
                <ul>
                    <li><strong>Suicide Risk:</strong> Currently Low (no SI/HI, good future planning)</li>
                    <li><strong>Violence Risk:</strong> Low (no history of aggression)</li>
                    <li><strong>Relapse Indicators:</strong> Sleep disturbance, social withdrawal, missing appointments</li>
                    <li><strong>Stressors to Monitor:</strong> Academic pressure, social relationships</li>
                </ul>
            </div>
        `
    },
    'contact': {
        title: 'Contact Information',
        body: `
            <div class="resource-card" style="background: linear-gradient(135deg, #EDE9FE 0%, #DDD6FE 100%); padding: 30px; border-radius: 15px; text-align: center;">
                <div class="icon-box" style="margin: 0 auto 20px; width: 80px; height: 80px; background: white; display: flex; align-items: center; justify-content: center; border-radius: 20px; box-shadow: 0 4px 15px rgba(124, 58, 237, 0.2);">
                    <i class="fas fa-user-graduate" style="font-size: 40px; color: #7C3AED;"></i>
                </div>
                <h3 style="color: #5B21B6; margin-bottom: 20px;">Srijan Dev</h3>
                <p style="color: #6B7280; margin-bottom: 30px;">Psychology Student | Schizophrenia Research Presentation</p>
                
                <div style="text-align: left; background: white; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h4 style="color: #7C3AED; margin-bottom: 15px;"><i class="fas fa-address-card"></i> Get in Touch</h4>
                    
                    <div style="margin: 15px 0; display: flex; align-items: center; gap: 15px;">
                        <i class="fas fa-phone" style="color: #7C3AED; font-size: 20px; width: 30px;"></i>
                        <div>
                            <p style="margin: 0; color: #4B5563; font-weight: 600;">Phone</p>
                            <a href="tel:+919412012157" style="color: #7C3AED; text-decoration: none; font-size: 18px;">+91 9412012157</a>
                        </div>
                    </div>
                    
                    <div style="margin: 15px 0; display: flex; align-items: center; gap: 15px;">
                        <i class="fas fa-envelope" style="color: #7C3AED; font-size: 20px; width: 30px;"></i>
                        <div>
                            <p style="margin: 0; color: #4B5563; font-weight: 600;">Primary Email</p>
                            <a href="mailto:srijandsofficial@gmail.com" style="color: #7C3AED; text-decoration: none;">srijandsofficial@gmail.com</a>
                        </div>
                    </div>
                    
                    <div style="margin: 15px 0; display: flex; align-items: center; gap: 15px;">
                        <i class="fas fa-envelope-open" style="color: #7C3AED; font-size: 20px; width: 30px;"></i>
                        <div>
                            <p style="margin: 0; color: #4B5563; font-weight: 600;">Alternative Email</p>
                            <a href="mailto:ssrijandev@gmail.com" style="color: #7C3AED; text-decoration: none;">ssrijandev@gmail.com</a>
                        </div>
                    </div>
                </div>
                
                <div style="background: #F3F4F6; padding: 20px; border-radius: 15px; margin-bottom: 20px;">
                    <h4 style="color: #7C3AED; margin-bottom: 10px;">Quick Actions</h4>
                    <div class="button-group" style="justify-content: center; margin-top: 15px;">
                        <button class="info-btn" onclick="window.location.href='tel:+919412012157'" style="background: #10B981;">
                            <i class="fas fa-phone"></i> Call Now
                        </button>
                        <button class="info-btn" onclick="window.location.href='mailto:srijandsofficial@gmail.com'">
                            <i class="fas fa-envelope"></i> Send Email
                        </button>
                        <button class="info-btn" onclick="copyContact()" style="background: #3B82F6;">
                            <i class="fas fa-copy"></i> Copy Contact
                        </button>
                    </div>
                </div>
                
                <div style="background: #FEF3C7; padding: 15px; border-radius: 10px; color: #92400E;">
                    <p style="margin: 0;"><i class="fas fa-clock"></i> Available for academic discussions and questions about this presentation</p>
                </div>
            </div>
            
            <div style="text-align: center; margin-top: 20px; color: #6B7280;">
                <p><i class="fas fa-university"></i> Psychology Department | 2024</p>
            </div>
        `
    },
    'clinical-assessment-tools': {
        title: 'Clinical Assessment Tools for Schizophrenia',
        body: `
            <div style="max-height: 600px; overflow-y: auto;">
                <!-- PANSS Scale -->
                <div class="resource-card" style="background: #EDE9FE; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #5B21B6; margin-bottom: 15px;">
                        <i class="fas fa-clipboard-check"></i> PANSS - Positive and Negative Syndrome Scale
                    </h3>
                    <p style="color: #6B7280; margin-bottom: 15px;">30-item rating scale (7-point severity scale: 1=absent to 7=extreme)</p>
                    
                    <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 15px; margin-top: 20px;">
                        <div style="background: white; padding: 15px; border-radius: 10px;">
                            <h4 style="color: #7C3AED; font-size: 14px;">Positive Scale (7 items)</h4>
                            <ul style="font-size: 13px; color: #4B5563; margin: 10px 0; padding-left: 20px;">
                                <li>P1: Delusions</li>
                                <li>P2: Conceptual disorganization</li>
                                <li>P3: Hallucinations</li>
                                <li>P4: Hyperactivity</li>
                                <li>P5: Grandiosity</li>
                                <li>P6: Suspiciousness</li>
                                <li>P7: Hostility</li>
                            </ul>
                        </div>
                        
                        <div style="background: white; padding: 15px; border-radius: 10px;">
                            <h4 style="color: #7C3AED; font-size: 14px;">Negative Scale (7 items)</h4>
                            <ul style="font-size: 13px; color: #4B5563; margin: 10px 0; padding-left: 20px;">
                                <li>N1: Blunted affect</li>
                                <li>N2: Emotional withdrawal</li>
                                <li>N3: Poor rapport</li>
                                <li>N4: Passive withdrawal</li>
                                <li>N5: Abstract thinking</li>
                                <li>N6: Spontaneity</li>
                                <li>N7: Stereotyped thinking</li>
                            </ul>
                        </div>
                        
                        <div style="background: white; padding: 15px; border-radius: 10px;">
                            <h4 style="color: #7C3AED; font-size: 14px;">General (16 items)</h4>
                            <p style="font-size: 13px; color: #4B5563;">Including anxiety, depression, cognitive symptoms, etc.</p>
                            <div style="margin-top: 10px;">
                                <span style="background: #7C3AED; color: white; padding: 5px 10px; border-radius: 15px; font-size: 12px;">
                                    Total Score: 30-210
                                </span>
                            </div>
                        </div>
                    </div>
                    
                    <button class="info-btn" onclick="openLink('https://www.psychiatrictimes.com/view/how-use-panss')" style="margin-top: 15px;">
                        <i class="fas fa-external-link-alt"></i> PANSS Training Guide
                    </button>
                </div>
                
                <!-- BPRS Scale -->
                <div class="resource-card" style="background: #DBEAFE; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #1E40AF; margin-bottom: 15px;">
                        <i class="fas fa-chart-line"></i> BPRS - Brief Psychiatric Rating Scale
                    </h3>
                    <p style="color: #6B7280;">18-item scale, each rated 1-7 based on severity</p>
                    
                    <div style="background: white; padding: 20px; border-radius: 10px; margin-top: 15px;">
                        <h4 style="color: #3B82F6; font-size: 16px; margin-bottom: 10px;">Key Domains Assessed:</h4>
                        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 15px;">
                            <div>
                                <h5 style="color: #1E40AF; font-size: 14px;">Psychotic Symptoms</h5>
                                <ul style="font-size: 13px; color: #4B5563; padding-left: 20px;">
                                    <li>Hallucinations</li>
                                    <li>Unusual thought content</li>
                                    <li>Bizarre behavior</li>
                                    <li>Disorientation</li>
                                </ul>
                            </div>
                            <div>
                                <h5 style="color: #1E40AF; font-size: 14px;">Mood & Affect</h5>
                                <ul style="font-size: 13px; color: #4B5563; padding-left: 20px;">
                                    <li>Anxiety</li>
                                    <li>Depression</li>
                                    <li>Suicidality</li>
                                    <li>Elevated mood</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- GAF Scale -->
                <div class="resource-card" style="background: #D1FAE5; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #065F46; margin-bottom: 15px;">
                        <i class="fas fa-tachometer-alt"></i> GAF - Global Assessment of Functioning
                    </h3>
                    <p style="color: #6B7280;">Scale from 0-100 measuring overall functioning</p>
                    
                    <table style="width: 100%; margin-top: 15px; background: white; border-radius: 10px; overflow: hidden;">
                        <tr style="background: #10B981; color: white;">
                            <th style="padding: 10px;">Score Range</th>
                            <th style="padding: 10px;">Functioning Level</th>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">91-100</td>
                            <td style="padding: 10px;">Superior functioning</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">81-90</td>
                            <td style="padding: 10px;">Absent or minimal symptoms</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">71-80</td>
                            <td style="padding: 10px;">Transient symptoms</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">61-70</td>
                            <td style="padding: 10px;">Mild symptoms</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">51-60</td>
                            <td style="padding: 10px;">Moderate symptoms</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">41-50</td>
                            <td style="padding: 10px;">Serious symptoms</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">31-40</td>
                            <td style="padding: 10px;">Major impairment</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">21-30</td>
                            <td style="padding: 10px;">Unable to function</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">11-20</td>
                            <td style="padding: 10px;">Needs constant supervision</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">1-10</td>
                            <td style="padding: 10px;">Persistent danger</td>
                        </tr>
                    </table>
                </div>
                
                <!-- CGI Scale -->
                <div class="resource-card" style="background: #FEF3C7; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #92400E; margin-bottom: 15px;">
                        <i class="fas fa-user-md"></i> CGI - Clinical Global Impression
                    </h3>
                    <p style="color: #6B7280;">Brief assessment of overall clinical status</p>
                    
                    <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 20px; margin-top: 20px;">
                        <div style="background: white; padding: 20px; border-radius: 10px;">
                            <h4 style="color: #D97706; font-size: 16px;">CGI-S (Severity)</h4>
                            <ol style="font-size: 14px; color: #4B5563; padding-left: 20px;">
                                <li>Normal, not ill</li>
                                <li>Borderline ill</li>
                                <li>Mildly ill</li>
                                <li>Moderately ill</li>
                                <li>Markedly ill</li>
                                <li>Severely ill</li>
                                <li>Extremely ill</li>
                            </ol>
                        </div>
                        
                        <div style="background: white; padding: 20px; border-radius: 10px;">
                            <h4 style="color: #D97706; font-size: 16px;">CGI-I (Improvement)</h4>
                            <ol style="font-size: 14px; color: #4B5563; padding-left: 20px;">
                                <li>Very much improved</li>
                                <li>Much improved</li>
                                <li>Minimally improved</li>
                                <li>No change</li>
                                <li>Minimally worse</li>
                                <li>Much worse</li>
                                <li>Very much worse</li>
                            </ol>
                        </div>
                    </div>
                </div>
                
                <!-- Quick Assessment Checklist -->
                <div class="resource-card" style="background: #F3F4F6; padding: 25px; border-radius: 15px;">
                    <h3 style="color: #4B5563; margin-bottom: 15px;">
                        <i class="fas fa-tasks"></i> Quick Clinical Assessment Checklist
                    </h3>
                    
                    <div style="background: white; padding: 20px; border-radius: 10px;">
                        <h4 style="color: #7C3AED; margin-bottom: 15px;">Mental Status Examination Components:</h4>
                        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 10px;">
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Appearance & Behavior
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Speech patterns
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Mood & Affect
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Thought Process
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Thought Content
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Perceptual Disturbances
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Cognition
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Insight & Judgment
                            </label>
                        </div>
                    </div>
                    
                    <div class="button-group" style="margin-top: 20px;">
                        <button class="info-btn" onclick="window.print()">
                            <i class="fas fa-print"></i> Print Assessment Forms
                        </button>
                        <button class="info-btn" onclick="downloadAssessmentPack()">
                            <i class="fas fa-download"></i> Download All Tools
                        </button>
                        <button class="info-btn" onclick="openLink('https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures')">
                            <i class="fas fa-book-medical"></i> More Resources
                        </button>
                    </div>
                </div>
            </div>
        `
    },
        'learn-history': {
        title: 'Historical Resources',
        body: `
            <div class="resource-card">
                <h4>Recommended Reading:</h4>
                <ul>
                    <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181977/" target="_blank">
                        History of Schizophrenia - NIH Article</a></li>
                    <li><a href="https://pubmed.ncbi.nlm.nih.gov/21305003/" target="_blank">
                        Evolution of the Schizophrenia Concept</a></li>
                </ul>
            </div>
        `
    },
    
    'contact': {
        title: 'Contact Information',
        body: `
            <div class="resource-card">
                <h4>Get in Touch:</h4>
                <p><i class="fas fa-envelope"></i> srijandsofficial@gmail.com/ssrijandev@gmail.com</p>
                <p><i class="fas fa-phone"></i> +91 9412012157</p>
                <p><i class="fas fa-globe"></i> SUNY</p>
            </div>
        `
    }
};

function downloadSlides() {
    // Create a simple download
    alert('Slides download feature would be implemented here. In a real application, this would generate a PDF.');
    // In real implementation: window.open('/path/to/slides.pdf', '_blank');
} 
// Function to copy contact information to clipboard
function copyContact() {
    const contactInfo = `
Srijan Dev
Phone: +91 9412012157
Email: srijandsofficial@gmail.com
Alt Email: ssrijandev@gmail.com
    `;
    
    // Create a temporary textarea element
    const textarea = document.createElement('textarea');
    textarea.value = contactInfo.trim();
    textarea.style.position = 'fixed';
    textarea.style.left = '-9999px';
    document.body.appendChild(textarea);
    
    // Select and copy the text
    textarea.select();
    document.execCommand('copy');
    document.body.removeChild(textarea);
    
    // Show confirmation
    alert('Contact information copied to clipboard!');
}

// Update the existing buttonContentData to include this contact info
if (typeof buttonContentData !== 'undefined') {
    buttonContentData['contact'] = contactContent['contact'];
} else {
    // If buttonContentData doesn't exist, create it
    window.buttonContentData = contactContent;
}

// Also update the last slide (Thank You slide) to include your name
document.addEventListener('DOMContentLoaded', function() {
    // Find the thank you slide and update it
    const slides = document.querySelectorAll('.slide');
    const lastSlide = slides[slides.length - 1];
    
    if (lastSlide) {
        const contactInfo = lastSlide.querySelector('p[style*="color: #9CA3AF"]');
        if (contactInfo) {
            contactInfo.innerHTML = 'Presented by: Srijan Dev | Psychology | 2025';
        }
    }
});

// Add footer with contact info to all slides (optional)
function addContactFooter() {
    const slides = document.querySelectorAll('.slide');
    slides.forEach((slide, index) => {
        // Skip the first and last slides
        if (index > 0 && index < slides.length - 1) {
            const footer = document.createElement('div');
            footer.style.cssText = `
                position: absolute;
                bottom: 20px;
                left: 30px;
                font-size: 12px;
                color: #9CA3AF;
            `;
            footer.innerHTML = '<i class="fas fa-user"></i> Srijan Dev | <i class="fas fa-envelope"></i> srijandsofficial@gmail.com';
            slide.appendChild(footer);
        }
    });
}

// Call this function if you want to add footer to all slides
// addContactFooter();

// Console message for debugging
console.log('Contact script loaded successfully!');
console.log('Contact: Srijan Dev');
console.log('Phone: +91 9412012157');
console.log('Email: srijandsofficial@gmail.com');
// Function to download assessment pack
function downloadAssessmentPack() {
    alert('Clinical Assessment Tools Pack\n\nThis would download:\n- PANSS Scale Form\n- BPRS Rating Form\n- GAF Scale Guide\n- CGI Scale Forms\n- MSE Template\n\nIn production, this would download a ZIP file with all assessment tools.');
}

// Add this to your existing buttonContentData
if (typeof buttonContentData !== 'undefined') {
    Object.assign(buttonContentData, clinicalAssessmentContent);
} else {
    window.buttonContentData = clinicalAssessmentContent;
}
// Complete Download Script for All Presentation Resources

// Main download function
function downloadFile(filename, content, type = 'text/plain') {
    const blob = new Blob([content], { type: type });
    const url = window.URL.createObjectURL(blob);
    const a = document.createElement('a');
    a.href = url;
    a.download = filename;
    document.body.appendChild(a);
    a.click();
    window.URL.revokeObjectURL(url);
    document.body.removeChild(a);
}

// Download presentation slides as HTML
function downloadPresentationSummary() {
    const summaryHTML = `
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Schizophrenia Spectrum Disorders - Complete Summary</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Arial', sans-serif;
            line-height: 1.6;
            color: #333;
            background-color: #f5f5f5;
            padding: 20px;
        }
        
        .container {
            max-width: 1000px;
            margin: 0 auto;
            background: white;
            padding: 40px;
            border-radius: 10px;
            box-shadow: 0 0 20px rgba(0,0,0,0.1);
        }
        
        h1 {
            color: #5B21B6;
            border-bottom: 3px solid #7C3AED;
            padding-bottom: 15px;
            margin-bottom: 30px;
            font-size: 2.5em;
        }
        
        h2 {
            color: #6D28D9;
            margin-top: 40px;
            margin-bottom: 20px;
            font-size: 1.8em;
            border-left: 4px solid #7C3AED;
            padding-left: 15px;
        }
        
        h3 {
            color: #7C3AED;
            margin-top: 25px;
            margin-bottom: 15px;
            font-size: 1.4em;
        }
        
        h4 {
            color: #8B5CF6;
            margin-top: 20px;
            margin-bottom: 10px;
            font-size: 1.2em;
        }
        
        p {
            margin-bottom: 15px;
            text-align: justify;
        }
        
        ul, ol {
            margin-left: 30px;
            margin-bottom: 20px;
        }
        
        li {
            margin-bottom: 8px;
        }
        
        .highlight {
            background-color: #FEF3C7;
            padding: 15px;
            border-radius: 8px;
            margin: 20px 0;
            border-left: 4px solid #F59E0B;
        }
        
        .info-box {
            background-color: #EDE9FE;
            padding: 20px;
            border-radius: 8px;
            margin: 20px 0;
            border-left: 4px solid #7C3AED;
        }
        
        .warning-box {
            background-color: #FEE2E2;
            padding: 20px;
            border-radius: 8px;
            margin: 20px 0;
            border-left: 4px solid #EF4444;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            background: white;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
        }
        
        th {
            background-color: #7C3AED;
            color: white;
            padding: 12px;
            text-align: left;
        }
        
        td {
            padding: 12px;
            border-bottom: 1px solid #e0e0e0;
        }
        
        tr:nth-child(even) {
            background-color: #f8f8f8;
        }
        
        .contact-info {
            background-color: #F3F4F6;
            padding: 20px;
            border-radius: 8px;
            margin-top: 40px;
            text-align: center;
        }
        
        .toc {
            background-color: #F9FAFB;
            padding: 25px;
            border-radius: 8px;
            margin-bottom: 40px;
        }
        
        .toc h3 {
            margin-bottom: 20px;
        }
        
        .toc ul {
            list-style-type: none;
            margin-left: 0;
        }
        
        .toc ul li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }
        
        .toc ul li:before {
            content: "▸";
            position: absolute;
            left: 0;
            color: #7C3AED;
        }
        
        .page-break {
            page-break-after: always;
        }
        
        @media print {
            body {
                background: white;
                padding: 0;
            }
            .container {
                box-shadow: none;
                padding: 20px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Schizophrenia Spectrum Disorders</h1>
        <p style="text-align: center; font-size: 1.2em; color: #6B7280; margin-bottom: 30px;">
            A Comprehensive Overview for Psychology Students
        </p>
        
        <div class="contact-info">
            <h3>Presented by: Srijan Dev</h3>
            <p>📧 Email: srijandsofficial@gmail.com | ssrijandev@gmail.com</p>
            <p>📱 Phone: +91 9412012157</p>
            <p>📅 Date: ${new Date().toLocaleDateString()}</p>
        </div>
        
        <div class="toc">
            <h3>Table of Contents</h3>
            <ul>
                <li>1. Introduction and Definition</li>
                <li>2. Historical Perspective</li>
                <li>3. Types of Schizophrenia Spectrum Disorders</li>
                <li>4. Symptoms: Positive and Negative</li>
                <li>5. DSM-5 Diagnostic Criteria</li>
                <li>6. Neurobiological Factors</li>
                <li>7. Environmental Risk Factors</li>
                <li>8. Treatment Approaches</li>
                <li>9. Recent Research Findings</li>
                <li>10. Case Studies</li>
                <li>11. Prognosis and Outcomes</li>
                <li>12. Future Directions</li>
                <li>13. References</li>
            </ul>
        </div>
        
        <h2>1. Introduction and Definition</h2>
        <div class="info-box">
            <p><strong>Definition:</strong> Schizophrenia is a chronic brain disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may experience hallucinations, delusions, and extremely disordered thinking and behavior that impairs daily functioning.</p>
        </div>
        
        <h3>Key Statistics</h3>
        <ul>
            <li>Affects approximately <strong>1%</strong> of the population worldwide</li>
            <li>Typical age of onset: <strong>20-30 years</strong></li>
            <li>Slightly more common in males than females</li>
            <li>Found in all cultures and socioeconomic groups</li>
        </ul>
        
        <h3>Core Features</h3>
        <ul>
            <li>Distortions in thinking (cognitive symptoms)</li>
            <li>Distortions in perception (hallucinations)</li>
            <li>Distortions in emotions (affective symptoms)</li>
            <li>Distortions in language (communication difficulties)</li>
            <li>Distortions in sense of self (ego disturbances)</li>
            <li>Distortions in behavior (disorganized or catatonic)</li>
        </ul>
        
        <div class="page-break"></div>
        
        <h2>2. Historical Perspective</h2>
        <table>
            <thead>
                <tr>
                    <th>Year</th>
                    <th>Milestone</th>
                    <th>Significance</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1887</td>
                    <td>Emil Kraepelin - "Dementia Praecox"</td>
                    <td>First clinical description of progressive psychotic disorder</td>
                </tr>
                <tr>
                    <td>1911</td>
                    <td>Eugen Bleuler - "Schizophrenia"</td>
                    <td>Coined the term meaning "split mind"</td>
                </tr>
                <tr>
                    <td>1950s</td>
                    <td>First Antipsychotics</td>
                    <td>Chlorpromazine revolutionized treatment</td>
                </tr>
                <tr>
                    <td>1980</td>
                    <td>DSM-III</td>
                    <td>Standardized diagnostic criteria established</td>
                </tr>
                <tr>
                    <td>2013</td>
                    <td>DSM-5</td>
                    <td>Introduction of Schizophrenia Spectrum concept</td>
                </tr>
            </tbody>
        </table>
        
        <h2>3. Schizophrenia Spectrum Disorders</h2>
        <p>The spectrum concept recognizes that psychotic disorders exist on a continuum of severity and duration:</p>
        
        <table>
            <thead>
                <tr>
                    <th>Disorder</th>
                    <th>Duration</th>
                    <th>Key Features</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td><strong>Schizotypal Personality Disorder</strong></td>
                    <td>Lifelong pattern</td>
                    <td>Odd beliefs, behavior, and speech; social deficits</td>
                </tr>
                <tr>
                    <td><strong>Delusional Disorder</strong></td>
                    <td>≥1 month</td>
                    <td>Fixed false beliefs without other psychotic symptoms</td>
                </tr>
                <tr>
                    <td><strong>Brief Psychotic Disorder</strong></td>
                    <td>1 day - 1 month</td>
                    <td>Sudden onset, often triggered by severe stress</td>
                </tr>
                <tr>
                    <td><strong>Schizophreniform Disorder</strong></td>
                    <td>1-6 months</td>
                    <td>Same symptoms as schizophrenia but shorter duration</td>
                </tr>
                <tr>
                    <td><strong>Schizophrenia</strong></td>
                    <td>≥6 months</td>
                    <td>Full syndrome with significant functional decline</td>
                </tr>
                <tr>
                    <td><strong>Schizoaffective Disorder</strong></td>
                    <td>Variable</td>
                    <td>Schizophrenia symptoms + major mood episodes</td>
                </tr>
            </tbody>
        </table>
        
        <div class="page-break"></div>
        
        <h2>4. Symptoms of Schizophrenia</h2>
        
        <h3>Positive Symptoms (Additions to Normal Experience)</h3>
        <div class="info-box">
            <h4>1. Hallucinations</h4>
            <ul>
                <li><strong>Auditory</strong> (most common - 70%): Hearing voices, sounds, or music</li>
                <li><strong>Visual</strong> (15-20%): Seeing things that aren't there</li>
                <li><strong>Tactile</strong>: Feeling sensations on the skin</li>
                <li><strong>Olfactory</strong>: Smelling odors that don't exist</li>
                <li><strong>Gustatory</strong>: Tasting things without eating</li>
            </ul>
            
            <h4>2. Delusions</h4>
            <ul>
                <li><strong>Persecutory</strong>: Belief that others are plotting against them</li>
                <li><strong>Referential</strong>: Belief that random events have personal meaning</li>
                <li><strong>Grandiose</strong>: Inflated sense of importance or abilities</li>
                <li><strong>Religious</strong>: Extreme religious beliefs</li>
                <li><strong>Somatic</strong>: False beliefs about body functions</li>
            </ul>
            
            <h4>3. Disorganized Speech</h4>
            <ul>
                <li>Loose associations (derailment)</li>
                <li>Tangential thinking</li>
                <li>Word salad (incomprehensible speech)</li>
                <li>Neologisms (made-up words)</li>
                <li>Clang associations (rhyming words)</li>
            </ul>
            
            <h4>4. Disorganized or Catatonic Behavior</h4>
            <ul>
                <li>Unpredictable agitation</li>
                <li>Bizarre postures or movements</li>
                <li>Excessive motor activity</li>
                <li>Echopraxia (imitating movements)</li>
                <li>Catatonic stupor (motionlessness)</li>
            </ul>
        </div>
        
        <h3>Negative Symptoms (Subtractions from Normal Experience)</h3>
        <div class="warning-box">
            <ul>
                <li><strong>Affective Flattening</strong>: Reduced emotional expression</li>
                <li><strong>Alogia</strong>: Poverty of speech</li>
                <li><strong>Avolition</strong>: Lack of motivation to pursue goals</li>
                <li><strong>Anhedonia</strong>: Inability to experience pleasure</li>
                <li><strong>Asociality</strong>: Social withdrawal and isolation</li>
            </ul>
        </div>
        
        <h3>Cognitive Symptoms</h3>
        <ul>
            <li>Impaired working memory</li>
            <li>Poor executive functioning</li>
            <li>Difficulty with attention and concentration</li>
            <li>Problems with processing speed</li>
            <li>Impaired verbal fluency</li>
        </ul>
        
        <div class="page-break"></div>
        <h2>5. DSM-5 Diagnostic Criteria for Schizophrenia</h2>
        <div class="highlight">
            <h4>Criterion A: Two or more of the following for ≥1 month:</h4>
            <ol>
                <li>Delusions</li>
                <li>Hallucinations</li>
                <li>Disorganized speech</li>
                <li>Grossly disorganized or catatonic behavior</li>
                <li>Negative symptoms</li>
            </ol>
            <p><em>Note: At least one must be (1), (2), or (3)</em></p>
        </div>
        
        <h4>Additional Criteria:</h4>
        <ul>
            <li><strong>B:</strong> Significant functional decline in work, relationships, or self-care</li>
            <li><strong>C:</strong> Continuous signs persist for at least 6 months</li>
            <li><strong>D:</strong> Schizoaffective and mood disorders ruled out</li>
            <li><strong>E:</strong> Not due to substances or medical conditions</li>
            <li><strong>F:</strong> If autism history, prominent delusions/hallucinations required</li>
        </ul>
        
        <h2>6. Neurobiological Factors</h2>
        
        <h3>Genetic Factors</h3>
        <table>
            <thead>
                <tr>
                    <th>Relationship to Affected Person</th>
                    <th>Risk of Developing Schizophrenia</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>General Population</td>
                    <td>1%</td>
                </tr>
                <tr>
                    <td>Sibling</td>
                    <td>9%</td>
                </tr>
                <tr>
                    <td>Fraternal Twin</td>
                    <td>17%</td>
                </tr>
                <tr>
                    <td>Identical Twin</td>
                    <td>48%</td>
                </tr>
                <tr>
                    <td>Both Parents Affected</td>
                    <td>46%</td>
                </tr>
            </tbody>
        </table>
        
        <h3>Brain Abnormalities</h3>
        <div class="info-box">
            <ul>
                <li><strong>Structural Changes:</strong>
                    <ul>
                        <li>Enlarged ventricles (25-30%)</li>
                        <li>Reduced gray matter volume</li>
                        <li>Frontal lobe dysfunction</li>
                        <li>Temporal lobe abnormalities</li>
                        <li>Hippocampal volume reduction (4-8%)</li>
                    </ul>
                </li>
                <li><strong>Neurotransmitter Imbalances:</strong>
                    <ul>
                        <li>Dopamine excess (positive symptoms)</li>
                        <li>Glutamate deficiency</li>
                        <li>GABA reduction</li>
                        <li>Serotonin alterations</li>
                    </ul>
                </li>
            </ul>
        </div>
        
        <div class="page-break"></div>
        
        <h2>7. Environmental Risk Factors</h2>
        
        <h3>Prenatal and Perinatal Factors</h3>
        <ul>
            <li>Maternal infections during pregnancy (influenza, toxoplasmosis)</li>
            <li>Malnutrition during pregnancy</li>
            <li>Birth complications and hypoxia</li>
            <li>Low birth weight</li>
            <li>Advanced paternal age</li>
        </ul>
        
        <h3>Environmental Stressors</h3>
        <ul>
            <li>Urban upbringing (2-3x increased risk)</li>
            <li>Migration and minority status</li>
            <li>Social isolation and defeat</li>
            <li>Childhood trauma and abuse</li>
            <li>Cannabis use during adolescence</li>
        </ul>
        
        <h2>8. Treatment Approaches</h2>
        
        <h3>Pharmacological Treatment</h3>
        <div class="info-box">
            <h4>First-Generation Antipsychotics (Typical)</h4>
            <ul>
                <li>Haloperidol (Haldol)</li>
                <li>Chlorpromazine (Thorazine)</li>
                <li>Fluphenazine (Prolixin)</li>
            </ul>
            <p><em>Primary action: Dopamine D2 receptor blockade</em></p>
            
            <h4>Second-Generation Antipsychotics (Atypical)</h4>
            <ul>
                <li>Risperidone (Risperdal)</li>
                <li>Olanzapine (Zyprexa)</li>
                <li>Quetiapine (Seroquel)</li>
                <li>Aripiprazole (Abilify)</li>
                <li>Clozapine (Clozaril) - for treatment-resistant cases</li>
            </ul>
            <p><em>Broader receptor profile, fewer movement side effects</em></p>
        </div>
        
        <h3>Psychosocial Interventions</h3>
        <ul>
            <li><strong>Cognitive Behavioral Therapy (CBT):</strong> Helps manage symptoms and improve functioning</li>
            <li><strong>Family Therapy:</strong> Reduces relapse rates by improving family dynamics</li>
            <li><strong>Social Skills Training:</strong> Improves interpersonal functioning</li>
            <li><strong>Cognitive Remediation:</strong> Targets cognitive deficits</li>
            <li><strong>Vocational Rehabilitation:</strong> Helps with employment</li>
            <li><strong>Assertive Community Treatment (ACT):</strong> Intensive case management</li>
        </ul>
        
        <div class="highlight">
            <p><strong>Combined Treatment:</strong> Studies show that medication + psychosocial interventions leads to 70% better outcomes compared to medication alone.</p>
        </div>
        
        <div class="page-break"></div>
        
        <h2>9. Recent Research Findings</h2>
        
        <h3>Genetic Studies (2022)</h3>
        <div class="info-box">
            <h4>Nature Publication - Schizophrenia Working Group</h4>
            <ul>
                <li>Sample: 76,755 cases and 243,649 controls</li>
                <li>Identified 287 genomic loci associated with schizophrenia</li>
                <li>120 genes directly implicated</li>
                <li>Key pathways: synaptic organization, neuronal excitability</li>
                <li>10 genes identified as potential therapeutic targets</li>
            </ul>
        </div>
        
        <h3>Brain Imaging Studies (2023)</h3>
        <div class="info-box">
            <h4>10-Year Longitudinal MRI Study</h4>
            <ul>
                <li>Progressive gray matter loss observed</li>
                <li>Ventricular enlargement continues over time</li>
                <li>Early intervention may slow progression</li>
                <li>Cognitive training shows neuroprotective effects</li>
            </ul>
        </div>
        
        <h2>10. Case Studies Summary</h2>
        
        <h3>Case 1: Early-Onset Schizophrenia - "James"</h3>
        <div class="highlight">
            <ul>
                <li><strong>Age:</strong> 22 years old</li>
                <li><strong>Onset:</strong> Age 18</li>
                <li><strong>Presentation:</strong> Auditory hallucinations, paranoid delusions</li>
                <li><strong>Treatment:</strong> Risperidone + CBT + family therapy</li>
                <li><strong>Outcome:</strong> Good recovery, returned to college part-time</li>
                <li><strong>Key Success Factors:</strong> Early intervention, family support, medication adherence</li>
            </ul>
        </div>
        
        <h3>Case 2: Treatment-Resistant Schizophrenia - "Sarah"</h3>
        <div class="warning-box">
            <ul>
                <li><strong>Age:</strong> 35 years old</li>
                <li><strong>Duration:</strong> 12 years</li>
                <li><strong>Failed Trials:</strong> Risperidone, Olanzapine, Aripiprazole</li>
                <li><strong>Current Treatment:</strong> Clozapine (2 years)</li>
                <li><strong>Outcome:</strong> 70% symptom reduction on clozapine</li>
                <li><strong>Lesson:</strong> Clozapine remains gold standard for treatment resistance</li>
            </ul>
        </div>
        
        <div class="page-break"></div>
        
        <h2>11. Prognosis and Long-term Outcomes</h2>
        
        <h3>Outcome Distribution</h3>
        <table>
            <thead>
                <tr>
                    <th>Outcome Category</th>
                    <th>Percentage</th>
                    <th>Description</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Good Recovery</td>
                    <td>25%</td>
                    <td>Return to premorbid functioning</td>
                </tr>
                <tr>
                    <td>Moderate Improvement</td>
                    <td>35%</td>
                    <td>Some symptoms, but able to function</td>
                </tr>
                <tr>
                    <td>Limited Improvement</td>
                    <td>25%</td>
                    <td>Significant ongoing symptoms</td>
                </tr>
                <tr>
                    <td>Poor Outcome</td>
                    <td>15%</td>
                    <td>Severe disability, frequent hospitalization</td>
                </tr>
            </tbody>
        </table>
        
        <h3>Prognostic Factors</h3>
        <div class="info-box">
            <h4>Favorable Factors:</h4>
            <ul>
                <li>Later age of onset</li>
                <li>Acute onset with identifiable stressor</li>
                <li>Good premorbid functioning</li>
                <li>Married or strong social support</li>
                <li>Positive symptoms predominant</li>
                <li>Good treatment adherence</li>
                <li>Female gender</li>
            </ul>
        </div>
        
        <div class="warning-box">
            <h4>Poor Prognostic Factors:</h4>
            <ul>
                <li>Early age of onset</li>
                <li>Insidious onset</li>
                <li>Poor premorbid functioning</li>
                <li>Social isolation</li>
                <li>Negative symptoms predominant</li>
                <li>Substance abuse</li>
                <li>Poor treatment compliance</li>
            </ul>
        </div>
        
        <h2>12. Future Directions</h2>
        
        <h3>Emerging Treatment Approaches</h3>
        <ul>
            <li><strong>Precision Medicine:</strong> Genetic testing to guide medication selection</li>
            <li><strong>Digital Therapeutics:</strong> Apps for symptom monitoring and therapy delivery</li>
            <li><strong>Neuromodulation:</strong> TMS and tDCS for cognitive symptoms</li>
            <li><strong>Novel Medications:</strong> Glutamate and GABA modulators</li>
            <li><strong>Immunotherapy:</strong> Targeting inflammation in schizophrenia</li>
        </ul>
        <h3>Research Priorities</h3>
        <ul>
            <li>Early detection biomarkers</li>
            <li>Prevention strategies for high-risk individuals</li>
            <li>Understanding the gut-brain axis</li>
            <li>Virtual reality therapy applications</li>
            <li>Peer support networks and recovery models</li>
        </ul>
        
        <div class="page-break"></div>
        
        <h2>13. Key Takeaways</h2>
        <div class="highlight">
            <ol>
                <li><strong>Complex Disorder:</strong> Schizophrenia involves multiple brain systems and has diverse presentations</li>
                <li><strong>Spectrum Concept:</strong> Recognition of various related disorders with different durations and severities</li>
                <li><strong>Multifactorial Etiology:</strong> Genetic vulnerability + environmental factors = increased risk</li>
                <li><strong>Treatment Works:</strong> Combination of medication and psychosocial interventions most effective</li>
                <li><strong>Early Intervention:</strong> Better outcomes with prompt treatment during first episode</li>
                <li><strong>Hope for Recovery:</strong> Many individuals lead fulfilling lives with proper treatment and support</li>
            </ol>
        </div>
        
        <h2>14. References</h2>
        <ol style="font-size: 0.9em;">
            <li>American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.</li>
            
            <li>Trubetskoy, V., et al. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.</li>
            
            <li>Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180(2), 156-168.</li>
            
            <li>Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687.</li>
            
            <li>Leucht, S., et al. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia. Schizophrenia Bulletin, 43(4), 837-851.</li>
            
            <li>McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophrenia—an overview. JAMA Psychiatry, 77(2), 201-210.</li>
            
            <li>Millan, M. J., et al. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485-515.</li>
            
            <li>Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97.</li>
            
            <li>Ripke, S., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427.</li>
            
            <li>World Health Organization. (2022). Schizophrenia Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia</li>
        </ol>
        
        <h2>15. Additional Resources</h2>
        <div class="info-box">
            <h4>Professional Organizations:</h4>
            <ul>
                <li>National Institute of Mental Health (NIMH): <a href="https://www.nimh.nih.gov">www.nimh.nih.gov</a></li>
                <li>American Psychiatric Association: <a href="https://www.psychiatry.org">www.psychiatry.org</a></li>
                <li>Schizophrenia International Research Society: <a href="https://schizophreniaresearchsociety.org">schizophreniaresearchsociety.org</a></li>
            </ul>
            
            <h4>Support Resources:</h4>
            <ul>
                <li>NAMI (National Alliance on Mental Illness): <a href="https://www.nami.org">www.nami.org</a></li>
                <li>SARDAA (Schizophrenia and Related Disorders Alliance): <a href="https://sardaa.org">sardaa.org</a></li>
                <li>Mental Health America: <a href="https://www.mhanational.org">www.mhanational.org</a></li>
            </ul>
            
            <h4>Educational Resources:</h4>
            <ul>
                <li>Cochrane Schizophrenia Group: Evidence-based reviews</li>
                <li>PubMed Central: Free access to research articles</li>
                <li>WHO mhGAP: Mental health guidelines</li>
            </ul>
        </div>
        
        <div class="contact-info" style="margin-top: 60px;">
            <h2>Contact Information</h2>
            <p><strong>Questions or discussions about this presentation?</strong></p>
            <h3>Srijan Dev</h3>
            <p>📧 Primary Email: <a href="mailto:srijandsofficial@gmail.com">srijandsofficial@gmail.com</a></p>
            <p>📧 Alternative Email: <a href="mailto:ssrijandev@gmail.com">ssrijandev@gmail.com</a></p>
            <p>📱 Phone: <a href="tel:+919412012157">+91 9412012157</a></p>
            <p style="margin-top: 20px; font-style: italic;">Thank you for your interest in understanding Schizophrenia Spectrum Disorders!</p>
        </div>
        
        <div style="text-align: center; margin-top: 40px; color: #6B7280;">
            <p>© 2025 - Psychology [SUNY]</p>
            <p>This document was generated on ${new Date().toLocaleString()}</p>
        </div>
    </div>
</body>
</html>
    `;
    
    // Download the HTML file
    downloadFile('Schizophrenia_Complete_Summary.html', summaryHTML, 'text/html');
    showDownloadSuccess('Complete presentation summary downloaded as HTML!');
}

// Add the function to global scope
window.downloadPresentationSummary = downloadPresentationSummary;

// You can also create a PDF-ready version
function downloadPrintableSummary() {
    const printCSS = `
        @media print {
            .page-break { page-break-after: always; }
            .no-print { display: none; }
            body { font-size: 11pt; }
            h1 { font-size: 24pt; }
            h2 { font-size: 18pt; }
            h3 { font-size: 14pt; }
        }
    `;
    
    // Open the summary in a new window for printing
    const printWindow = window.open('', '_blank');
    printWindow.document.write(summaryHTML.replace('</style>', printCSS + '</style>'));
    printWindow.document.close();
    
    setTimeout(() => {
        printWindow.print();
    }, 500);
}

window.downloadPrintableSummary = downloadPrintableSummary;
// Download DSM-5 Checklist
function downloadDSM5Checklist() {
    const checklistContent = `
DSM-5 DIAGNOSTIC CRITERIA FOR SCHIZOPHRENIA
==========================================
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com
Date: ${new Date().toLocaleDateString()}

CRITERION A: Two (or more) of the following, each present for a significant portion of time during a 1-month period:

□ 1. Delusions
□ 2. Hallucinations
□ 3. Disorganized speech (e.g., frequent derailment or incoherence)
□ 4. Grossly disorganized or catatonic behavior
□ 5. Negative symptoms (i.e., diminished emotional expression or avolition)

Note: At least one of these must be (1), (2), or (3)

CRITERION B:
□ For a significant portion of the time since onset, level of functioning in major areas is markedly below pre-onset level

CRITERION C:
□ Continuous signs of disturbance persist for at least 6 months

CRITERION D:
□ Schizoaffective disorder and depressive/bipolar disorder with psychotic features ruled out

CRITERION E:
□ Not attributable to physiological effects of a substance or medical condition

CRITERION F:
□ If history of autism spectrum disorder or communication disorder, additional diagnosis of schizophrenia only if prominent delusions or hallucinations are present for at least 1 month

SEVERITY SPECIFIERS:
□ First episode, currently in acute episode
□ First episode, currently in partial remission
□ First episode, currently in full remission
□ Multiple episodes, currently in acute episode
□ Multiple episodes, currently in partial remission
□ Multiple episodes, currently in full remission
□ Continuous
□ Unspecified

CLINICIAN: _____________________
DATE: _________________________
PATIENT ID: ___________________
    `;
    
    downloadFile('DSM5_Schizophrenia_Checklist.txt', checklistContent);
    showDownloadSuccess('DSM-5 Checklist downloaded!');
}

// Download PANSS Scale Form
function downloadPANSSForm() {
    const panssContent = `
POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS)
============================================
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com

Patient: _________________ Date: _________ Rater: _________________

RATING SCALE: 1=Absent, 2=Minimal, 3=Mild, 4=Moderate, 5=Moderate-Severe, 6=Severe, 7=Extreme

POSITIVE SCALE (P)
P1. Delusions                              [1][2][3][4][5][6][7]
P2. Conceptual disorganization             [1][2][3][4][5][6][7]
P3. Hallucinatory behavior                 [1][2][3][4][5][6][7]
P4. Excitement                             [1][2][3][4][5][6][7]
P5. Grandiosity                            [1][2][3][4][5][6][7]
P6. Suspiciousness/persecution             [1][2][3][4][5][6][7]
P7. Hostility                              [1][2][3][4][5][6][7]
                            Positive Total: _____

NEGATIVE SCALE (N)
N1. Blunted affect                         [1][2][3][4][5][6][7]
N2. Emotional withdrawal                   [1][2][3][4][5][6][7]
N3. Poor rapport                           [1][2][3][4][5][6][7]
N4. Passive/apathetic social withdrawal    [1][2][3][4][5][6][7]
N5. Difficulty in abstract thinking        [1][2][3][4][5][6][7]
N6. Lack of spontaneity & flow            [1][2][3][4][5][6][7]
N7. Stereotyped thinking                   [1][2][3][4][5][6][7]
                            Negative Total: _____

GENERAL PSYCHOPATHOLOGY (G)
G1. Somatic concern                        [1][2][3][4][5][6][7]
G2. Anxiety                                [1][2][3][4][5][6][7]
G3. Guilt feelings                         [1][2][3][4][5][6][7]
G4. Tension                                [1][2][3][4][5][6][7]
G5. Mannerisms and posturing              [1][2][3][4][5][6][7]
G6. Depression                             [1][2][3][4][5][6][7]
G7. Motor retardation                      [1][2][3][4][5][6][7]
G8. Uncooperativeness                      [1][2][3][4][5][6][7]
G9. Unusual thought content                [1][2][3][4][5][6][7]
G10. Disorientation                        [1][2][3][4][5][6][7]
G11. Poor attention                        [1][2][3][4][5][6][7]
G12. Lack of judgment & insight            [1][2][3][4][5][6][7]
G13. Disturbance of volition               [1][2][3][4][5][6][7]
G14. Poor impulse control                  [1][2][3][4][5][6][7]
G15. Preoccupation                         [1][2][3][4][5][6][7]
G16. Active social avoidance               [1][2][3][4][5][6][7]
                            General Total: _____

TOTAL PANSS SCORE: _____
    `;
    
    downloadFile('PANSS_Assessment_Form.txt', panssContent);
    showDownloadSuccess('PANSS Form downloaded!');
}

// Download Clinical Assessment Pack
function downloadAssessmentPack() {
    const assessmentContent = `
CLINICAL ASSESSMENT TOOLS FOR SCHIZOPHRENIA
===========================================
Comprehensive Assessment Package
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com

This package includes:
1. DSM-5 Diagnostic Criteria Checklist
2. PANSS Rating Scale
3. Brief Psychiatric Rating Scale (BPRS)
4. Global Assessment of Functioning (GAF)
5. Clinical Global Impression (CGI)
6. Mental Status Examination Template

===========================================
1. MENTAL STATUS EXAMINATION TEMPLATE
===========================================

Date: _________ Time: _________ Examiner: _________________
Patient: _________________ Age: _____ ID: _________________

APPEARANCE & BEHAVIOR:
□ Well-groomed  □ Disheveled  □ Bizarre dress
□ Cooperative   □ Guarded     □ Hostile
□ Psychomotor agitation  □ Psychomotor retardation
Notes: ________________________________________________

SPEECH:
Rate: □ Normal  □ Slow  □ Rapid
Volume: □ Normal  □ Soft  □ Loud
Coherence: □ Coherent  □ Tangential  □ Circumstantial  □ Incoherent
Notes: ________________________________________________

MOOD & AFFECT:
Mood (subjective): ____________________________________
Affect: □ Appropriate  □ Flat  □ Blunted  □ Labile
Congruence: □ Congruent  □ Incongruent
Notes: ________________________________________________

THOUGHT PROCESS:
□ Linear  □ Circumstantial  □ Tangential  □ Loose associations
□ Flight of ideas  □ Thought blocking  □ Perseveration
Notes: ________________________________________________

THOUGHT CONTENT:
□ No abnormalities
□ Delusions (type): ___________________________________
□ Obsessions  □ Phobias  □ Suicidal ideation  □ Homicidal ideation
Notes: ________________________________________________

PERCEPTUAL DISTURBANCES:
□ None reported
□ Auditory hallucinations  □ Visual hallucinations
□ Tactile  □ Olfactory  □ Gustatory
□ Illusions  □ Depersonalization  □ Derealization
Notes: ________________________________________________

COGNITION:
Orientation: □ Person  □ Place  □ Time  □ Situation
Memory: □ Intact  □ Impaired (specify): ________________
Concentration: □ Good  □ Fair  □ Poor
Abstract thinking: □ Intact  □ Concrete
Notes: ________________________________________________

INSIGHT & JUDGMENT:
Insight: □ Good  □ Fair  □ Poor  □ None
Judgment: □ Good  □ Fair  □ Poor
Notes: ________________________________________________

RISK ASSESSMENT:
Suicide risk: □ Low  □ Moderate  □ High
Violence risk: □ Low  □ Moderate  □ High
Self-neglect: □ Low  □ Moderate  □ High
Notes: ________________________________________________

DIAGNOSTIC IMPRESSION:
_______________________________________________________
_______________________________________________________

RECOMMENDATIONS:
_______________________________________________________
_______________________________________________________

Examiner Signature: _________________ Date: ____________
    `;
    
    downloadFile('Clinical_Assessment_Tools_Schizophrenia.txt', assessmentContent);
    showDownloadSuccess('Complete Assessment Package downloaded!');
}

// Download References
function downloadReferences() {
    const referencesContent = `
SCHIZOPHRENIA SPECTRUM DISORDERS - REFERENCES
============================================
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

2. Trubetskoy, V., et al. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.

3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia:
3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180(2), 156-168.

4. Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687.

5. Leucht, S., et al. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia. Schizophrenia Bulletin, 43(4), 837-851.

6. McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophrenia—an overview. JAMA Psychiatry, 77(2), 201-210.

7. Millan, M. J., et al. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485-515.

8. Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97.

9. Ripke, S., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427.

10. Stahl, S. M. (2018). Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis. CNS Spectrums, 23(3), 187-191.

11. Van Os, J., & Kapur, S. (2009). Schizophrenia. The Lancet, 374(9690), 635-645.

12. World Health Organization. (2022). Schizophrenia Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia

13. Jauhar, S., et al. (2022). Cognitive-behavioural therapy for the symptoms of schizophrenia. The British Journal of Psychiatry, 220(3), 134-142.

14. Kane, J. M., & Correll, C. U. (2022). Treatment-resistant schizophrenia: Definition and assessment. The Journal of Clinical Psychiatry, 83(5), MS21078COM5.

ADDITIONAL RESOURCES:
- National Institute of Mental Health: https://www.nimh.nih.gov/health/topics/schizophrenia
- NAMI (National Alliance on Mental Illness): https://www.nami.org
- Schizophrenia International Research Society: https://schizophreniaresearchsociety.org
- Cochrane Schizophrenia Group: https://schizophrenia.cochrane.org

Downloaded on: ${new Date().toLocaleString()}
    `;
    
    downloadFile('Schizophrenia_References_Complete.txt', referencesContent);
    showDownloadSuccess('References downloaded!');
}

// Download Study Notes
function downloadStudyNotes() {
    const studyNotesContent = `
SCHIZOPHRENIA SPECTRUM DISORDERS - STUDY NOTES
==============================================
Psychology Class Presentation
By: Srijan Dev | Contact: +91 9412012157 | srijandsofficial@gmail.com

KEY CONCEPTS TO REMEMBER:
========================

1. DEFINITION
- Chronic brain disorder affecting thinking, perception, emotions, and behavior
- Affects approximately 1% of the population worldwide
- Typical onset: late adolescence to early adulthood (20-30 years)

2. SCHIZOPHRENIA SPECTRUM DISORDERS
- Schizotypal Personality Disorder (lifelong pattern)
- Delusional Disorder (≥1 month, only delusions)
- Brief Psychotic Disorder (1 day - 1 month)
- Schizophreniform Disorder (1-6 months)
- Schizophrenia (≥6 months)
- Schizoaffective Disorder (schizophrenia + mood episodes)

3. POSITIVE SYMPTOMS (additions to normal experience)
- Hallucinations (70% auditory)
- Delusions (fixed false beliefs)
- Disorganized speech
- Disorganized behavior

4. NEGATIVE SYMPTOMS (subtractions from normal experience)
- Affective flattening
- Alogia (poverty of speech)
- Avolition (lack of motivation)
- Anhedonia (inability to feel pleasure)
- Asociality (social withdrawal)

5. NEUROBIOLOGY
- Dopamine hypothesis (excess dopamine)
- Glutamate deficiency
- Brain structure changes:
  * Enlarged ventricles (25-30%)
  * Reduced gray matter
  * Frontal and temporal lobe abnormalities

6. RISK FACTORS
Genetic:
- General population: 1%
- Sibling of affected person: 9%
- Fraternal twin: 17%
- Identical twin: 48%

Environmental:
- Prenatal infections
- Birth complications
- Urban upbringing
- Cannabis use in adolescence
- Childhood trauma

7. TREATMENT
Medications:
- First-generation: Haloperidol, Chlorpromazine
- Second-generation: Risperidone, Olanzapine, Quetiapine, Aripiprazole
- Clozapine for treatment-resistant cases

Psychosocial:
- Cognitive Behavioral Therapy (CBT)
- Family therapy
- Social skills training
- Vocational rehabilitation

8. PROGNOSIS
- 25% Good recovery
- 35% Moderate improvement
- 25% Limited improvement
- 15% Poor outcome

Favorable factors: Later onset, acute onset, good premorbid functioning
Poor factors: Early onset, insidious onset, negative symptoms predominant

EXAM TIPS:
=========
1. Know DSM-5 criteria (A-F)
2. Distinguish positive vs negative symptoms
3. Understand dopamine hypothesis
4. Remember genetic risk percentages
5. Know medication categories
6. Understand spectrum concept

Contact for questions: Srijan Dev
Email: srijandsofficial@gmail.com | ssrijandev@gmail.com
Phone: +91 9412012157
    `;
    
    downloadFile('Schizophrenia_Study_Notes.txt', studyNotesContent);
    showDownloadSuccess('Study notes downloaded!');
}

// Download All Materials as Package
function downloadAllMaterials() {
    // Create a timestamp
    const timestamp = new Date().toISOString().slice(0, 10);
    
    // Show what would be downloaded
    const packageContents = `
SCHIZOPHRENIA SPECTRUM DISORDERS - COMPLETE PACKAGE
==================================================
Downloaded by: User
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com
Date: ${timestamp}

This package contains:
1. ✓ Presentation Slides (HTML format)
2. ✓ DSM-5 Diagnostic Checklist
3. ✓ PANSS Assessment Form
4. ✓ Clinical Assessment Tools
5. ✓ Complete References List
6. ✓ Study Notes Summary
7. ✓ Mental Status Examination Template
8. ✓ Case Study Materials

To download individual components, use the specific download buttons throughout the presentation.

Thank you for attending this presentation!

For questions or additional resources, contact:
Srijan Dev
Phone: +91 9412012157
Email: srijandsofficial@gmail.com
Alternative: ssrijandev@gmail.com
    `;
    
    // In a real implementation, this would create a ZIP file
    alert('Downloading Complete Package...\n\nThis would download all materials as a ZIP file.\n\nFor now, please use individual download buttons for specific resources.');
    
    // Download package info
    downloadFile(`Schizophrenia_Package_Info_${timestamp}.txt`, packageContents);
}

// Show download success message
function showDownloadSuccess(message) {
    // Create a temporary success notification
    const notification = document.createElement('div');
    notification.style.cssText = `
        position: fixed;
        bottom: 20px;
        right: 20px;
        background: #10B981;
        color: white;
        padding: 15px 25px;
        border-radius: 10px;
        box-shadow: 0 4px 15px rgba(0,0,0,0.2);
        z-index: 10000;
        animation: slideIn 0.3s ease-out;
    `;
    notification.innerHTML = `<i class="fas fa-check-circle"></i> ${message}`;
    
    document.body.appendChild(notification);
    
    setTimeout(() => {
        notification.style.animation = 'fadeOut 0.3s ease-out';
        setTimeout(() => {
            document.body.removeChild(notification);
        }, 300);
    }, 3000);
}

// Add CSS for notifications
const style = document.createElement('style');
style.textContent = `
    @keyframes slideIn {
        from { transform: translateX(100%); opacity: 0; }
        to { transform: translateX(0); opacity: 1; }
    }
    @keyframes fadeOut {
        from { opacity: 1; }
        to { opacity: 0; }
    }
`;
document.head.appendChild(style);

// Export functions to global scope for button onclick handlers
window.downloadSlides = downloadSlides;
window.downloadDSM5Checklist = downloadDSM5Checklist;
window.downloadPANSSForm = downloadPANSSForm;
window.downloadAssessmentPack = downloadAssessmentPack;
window.downloadReferences = downloadReferences;
window.downloadStudyNotes = downloadStudyNotes;
window.downloadAllMaterials = downloadAllMaterials;

// Add download buttons to relevant slides
document.addEventListener('DOMContentLoaded', function() {
    console.log('Download script loaded successfully!');
    console.log('Available downloads: Slides, DSM-5 Checklist, PANSS Form, Assessment Pack, References, Study Notes');
});
    </script>
</body>
</html>